key: cord-0075924-olthl2q7 authors: nan title: Critical Care Canada Forum 2021 Abstracts date: 2022-03-21 journal: Can J Anaesth DOI: 10.1007/s12630-022-02207-2 sha: 3add213c32462c513cec07a57e2c37b540196734 doc_id: 75924 cord_uid: olthl2q7 nan . During the third wave of the COVID-19 pandemic in Ontario, the province experienced a surge in the number of adults requiring ICU admission and ECMO for COVID-19. The Hospital for Sick Children's (SickKids) PICU participated in expanding the provincial ICU capacity by admitting critically ill adult patients with COVID-19, with the ability to provide ECMO if required. Objectives: We review the steps undertaken to adapt the pediatric COVID-19 ECMO practices and ensure readiness to pivot to support adults on ECMO with personnel, equipment and supplies, and the approaches used to sustain the program during the 3month period. Methods: SickKids ECLS Program collaborated with the University Health Network's (UHN) ECLS Program to understand adult COVID-19 VV-ECMO management practices. UNH's COVID-19 VV-ECMO management practices and post decannulation guidelines were obtained, reviewed, and incorporated into existing ECMO management guidelines. Clinicians from the SickKids ECLS Program participated in UHN's weekly virtual ECLS patient summary rounds and UHN surgeons were invited to attend daily virtual bedside ECLS rounds in the SickKids PICU for added real time decision making and support. A virtual education session was developed and recorded to share current evidence based adult COVID-19 VV-ECMO management guidelines and to highlight practice differences. Cannulas and membranes suited for adults were ordered. Cardiology, Thrombosis, and ENT consultant services adapted their imaging, laboratory testing and procedural support as required. Results: From April to June 2021, 36 adult patients with COVID-19 were admitted to SickKids PICU. Thirty required intubation and mechanical ventilation and eight were supported on VV-ECMO. Five were cannulated and decannulated in the PICU; 3 were transferred in already cannulated and transferred back to UHN on ECMO. Median time on VV-ECMO at SickKids was 19 days. 50% of ECMO patients also required continuous renal replacement therapy connected through the ECMO circuit. Four patients were separated from VV-ECMO, extubated, and discharged to an adult hospital COVID-19 ward; 3 patients were transferred back to UHN on VV-ECMO for continued management, and one patient died after compassionate separation from ECMO due to multi-organ failure. Minor differences between pediatric and adult practices were associated with anticoagulation (using PTT as heparin laboratory monitoring and discontinuing heparin for bleeding complications). Major practice differences included: using bedside percutaneous ECMO cannula insertions with transesophageal echocardiogram guidance, percutaneous tracheostomy insertion using disposable bronchoscopes, decannulation from ECMO without vascular reconstructions, and avoidance of ECPR. Conclusion: The SickKids ECLS Program was successfully able to rapidly adapt and care for critically ill adults with COVID-19 requiring VV-ECMO through education sessions for staff, collaboration with the UHN ECLS Program and integration of adult practices into an already mature pediatric ECLS program. Relevant experience gained from the management of adult patients will be incorporated into existing pediatric VV-ECMO management and applied to the older pediatric and adolescent patients cared for in the future. AlZadjali, Ammar Background: In Pediatric Critical Care practice, Spinal Muscular Atrophy (SMA) is the most frequently seen degenerative neuromuscular disease. Emerging therapies have improved the long-term outlook for these children. Ensuring excellent care during times of critical acute illness is increasingly important to avoid the negative long-term consequences of poor growth, muscle loss, chronic respiratory failure, and the developmental and psychosocial harms associated with prolonged critical illness hospitalization. Objective: We report on the development and implementation of evidence-based pediatric critical care guidelines informing team-based care for children with SMA and their families. Guideline development, dissemination, uptake, evaluation, and sustainment strategies will be described. Method: A realist literature review was completed by an interprofessional team. Current local practices were compared to the evidence extracted from the literature and key practice improvement domains were collaboratively determined. Best practice guidance for multidisciplinary care was developed within each priority domain, integrating evidence, stakeholder, and expert opinion. Guidelines were then refined to fit in the local context of care and available resources. The resulting practice guidelines were disseminated through education and specific process tools in preparation for program-wide implementation. A formative and summative integrated evaluation plan was designed that included measures of guideline adherence, education outcomes, user feedback, and the sustainment of new practice behaviors. Results: A search of 5 databases and expert knowledge of the literature identified 404 titles of which 120 were included for full-text review. Evidence from six emerging priority domains: respiratory care, family experience, nutrition, outcomes, pharmacological care, physiotherapy care, and rehabilitation were extracted. Practice recommendations for each domain were translated into the organization's electronic medical record as a set of standardized admission orders. Recommendations not suited to standardized orders were incorporated into a best practice guidelines document. Implementation interventions were developed including discipline/rolefocused education presentations, self-learning modules, and a program-wide awareness campaign. All of the tools developed were adapted for access during pandemic restrictions and integrated into standing educational platforms. Conclusion: Children with SMA and their families have unique needs during critical illness. Advancements in treatment are encouraging for enhancing the quality of life for these children and the critical care team needs to ensure that care is aligned with the best evidence to ensure these quality outcomes are achieved. Ongoing rapid-cycle evaluation of these guidelines and the resulting practice and systems changes are necessary to sustain practice improvements and ensure the evolving needs of this fragile population are met. Arora, Jaskirat Background: The unprecedented demand for sedative agents during the COVID-19 pandemic resulted in worldwide shortages of commonly used intravenous sedation medications such as propofol and fentanyl. One method of conserving the supply of sedative agents is administering volatile anesthetics for long-term sedation. Volatile anesthetic agents, such as isoflurane, have been used for general anesthesia in operating rooms for more than 150 years, but are not routinely used to sedate mechanically ventilated patients in the intensive care unit (1) . The safe administration of volatile anesthetics requires the means to safely deliver these medications with standard ventilators within established protocols while ensuring the safety of the critical care environment and the healthcare professionals that work there (2) (3) (4) . The Anesthetic Conservation Device (AnaConDa) is a single-use device that allows for the safe delivery of isoflurane to patients in critical care settings. Objective: The implementation of a safe supplemental sedation regimen using isoflurane with AnaConDa in a COVID-19 intensive care unit to mitigate the impact of sedation shortages. Methods: A coordinated, multidisciplinary approach involving respiratory therapists, pharmacists, nurses and physicians was used to operationalize the safe use of AnaConDa into daily practice. A comprehensive review of the literature and prior protocols, stakeholder meetings and expert engagement, including physicians and staff involved in previous research were used to create a guidance document for isoflurane administration using the AnaConDa. Results: Over the course May and June 2020, training resources and a staff education plan were developed and implemented to ensure patient, staff and environmental safety. Education and training sessions were conducted for respiratory therapists, critical care nurses, pharmacists, residents and fellows on the routine operation of the AnaConDa, required patient monitoring and the identification and management of potential complications of volatile anesthetic gasses. A total of 44 respiratory therapists, a core group of 30 critical care nurses were trained using in-services and supported by bedside training as necessary. A total of 6 patients successfully received supplemental sedation using the AnaConDa in the post implementation phase. Additional supportive materials were developed, including a standard order set, documentation flowsheet, and a bedside clinical reference guide. Further safety protocols for isoflurane administration included flags in the electronic patient records and designated, secure storage locations. Conclusion: We successfully created capacity to safely deliver a supplemental method of sedation therapy for critically-ill COVID-19 patients requiring mechanical ventilation in intensive care. This method of sedation is part of a comprehensive strategy to achieve sedation goals the intensive care. This included the creation of approved order sets, educational material, interprofessional staff training and ongoing staff 20 support amidst the many competing priorities during the pandemic. Ongoing clinical trials are required to establish the effects of inhalational sedation on ventilation, delirium, and clinical outcomes. Introduction: Ancillary tests are widely used to diagnose death by neurological criteria (DNC), particularly in patients with unreliable or incomplete clinical examinations [1] [2] [3] . Despite their importance in DNC determination, ancillary test use in clinical practice is heterogeneous and their respective diagnostic accuracy is unclear. Objective: To synthesize the diagnostic accuracy (sensitivity and specificity) of ancillary tests used in clinical practice to diagnose DNC among comatose patients. Methods: We performed a systematic review and meta-analysis by searching MEDLINE, EMBASE and Cochrane Central databases from their inception to April 21, 2020 4. We selected published abstracts and manuscripts reporting cohort and casecontrol studies, as well as case series, including deeply comatose patients who underwent ancillary testing (neuroimaging, neurophysiology) for DNC determination. Accepted reference standards were clinical examination, four-vessel angiography, and radionuclide imaging. Two individuals independently extracted data and assessed study risk of bias using the QUADAS-2 tool. We estimated ancillary test sensitivities and specificities using a mixed-effects Bayesian hierarchical model with studies nested within ancillary test types. Results: The search strategy yielded 4208 publications, of which 40 satisfied selection criteria (N=2744 ancillary tests applied). One study had low risk of bias on all QUADAS-2 domains. Reference standards were clinical examination in 37/40 (92.5%) studies and four-vessel angiography in 3/40 (7.5%) studies. Ancillary tests were CTangiography (4-point, 7-point and 10-point scales, and no intracranial flow criteria), CTperfusion scan, radionuclide imaging (with technetium [99m Tc] pertechnetate angiography, 99m Tc diethylenetriamine pentaacetate [DTPA] angiography, 99m Tc hexamethylpropylene amine oxime [HMPAO] angiography, 99m Tc HMPAO perfusion with and without single-photon emission computed tomography [SPECT] , 99m Tc HMPAO angiography, and other criteria), transcranial Doppler ultrasound, cortical electroencephalography, magnetic resonance imaging (time-of-flight angiography, diffused weighted imaging and apparent diffusion coefficient [DWI/ADC]), magnetic resonance venography and evoked potentials (brainstem auditory and somatosensory). Data was most abundant for transcranial Doppler ultrasound (40.4% of applied ATs), CT-angiography (4-point scale; 11.0%) and electroencephalography (9.6%). The Figure reports pooled ancillary test sensitivities and specificities, with respective 95% highest density intervals. Overall, ancillary tests had variable pooled sensitivities (0.81-1.00) and specificities (0.84-1.00). Wide highest density intervals were observed for several ancillary tests, reflecting significant uncertainty in pooled diagnostic accuracy estimates. Conclusion: Studies assessing the diagnostic accuracy of ancillary tests for DNC have unclear or high risk of bias. Most ancillary tests have imperfect or imprecise diagnostic accuracy (sensitivity and specificity). Further research is required to identify accurate ancillary tests for DNC determination. Pooled ancillary test sensitivities and specificities, with respective 95% highest density intervals 1 . Differences in practice needs to be clarified to ensure the best use of scarce resources and optimal patient outcomes during this pandemic. Objective: The objective of this study is to determine how Canadian critical care physicians apply evidence-based strategies to the management of ARDS in the context of the COVID-19 pandemic. Methods: In a national cross-sectional survey, we developed, tested, and administered an electronic questionnaire to 12 critical care departments across Canada. Critical care attendings and fellows were included in the survey distribution. The questionnaire included assessment on critical care physicians' demographic data, ARDS management strategy importance (5-point Likert scale), ARDS management thresholds (multiple-select questions), and opinion on ARDS COVID-19 (open-text). Data was collected through a secure web-based electronic platform (Qualtrics). Results: A total of 74 critical care physicians participated in the survey. The majority of respondents had specialty training in internal medicine (49%), greater than 10 years of experience in critical care medicine (42%) and were located at a university-affiliated centre (91%). ARDS net ventilation and prone positioning were seen as the most important management strategies with 97% and 89% of respondents, respectively, stating they were very or extremely important. Inhaled nitric oxide and physical examination were the least important, with 67% and 34% of respondents, respectively, stating they were not at all important or slightly important. The most common thresholds for use of ARDS management techniques included daily (59%) physical examination, clinical deterioration (90%) on chest x-ray, ventilator dys-synchrony (75%) for muscle relaxants, PF ratio 100 -150 (84%) for prone positioning, right ventricular (RV) dysfunction (53%) for inhaled nitric oxides, routine (49%) for steroids, and as per local extracorporeal membrane oxygenation (ECMO) centre protocol (84%) for EMCO referral. Common themes when asked for additional management strategies that were seen as beneficial for COVID ARDS included medications (34%), medical interventions (42%), and conservative approaches (36%). Specifically, the most common included Tocilizumab (17%), PEEP (positive end-expiratory pressure) titration (15%), and delayed intubation and prognostication (12%). Conclusion: In the context of COVID-19 pandemic, there is some agreement amongst critical care physicians about what is important in the management of ARDS, whether it be management strategies or thresholds for use. However, there is a disconnect with individuals' thoughts and actions, specifically when looking at perspectives on physical examination. When not prompted, there was still some form of consensus on beneficial strategies for treating ARDS COVID. Overall, these factors combined suggest variability in practice between physicians may not be as inconsistent as previously thought. Introduction: High frequency data streams of vital signs can be used to generate individualized hemodynamic targets for critically ill patients. However, central to this precision medicine approach to resuscitation is our ability to screen these data streams for errors and artifacts. Arterial line data which is used to derive these targets are prone to artifacts due to reasons such as blood sampling, malpositioning, line flushing, and calibration procedures. Various methods have been used to assess artifacts including models that implement arbitrary thresholds or average data over large time intervals 1 . More stringent methods for artifact cleaning are needed to capture changes that appear physiologic and to preserve data granularity. There is no consensus on the best method for data cleaning. Objectives: To determine whether an error-checking algorithm that assesses the relationship between systolic, diastolic, and mean arterial blood pressure data developed for intraoperative use 1 can be applied to high volumes of arterial line data in an ICU population. Methods: High frequency blood pressure data from a nested cohort of ICU patients enrolled in the CONFOCAL-2 study were analyzed. Systolic, diastolic, and mean arterial pressure values were derived from waveforms captured at 240Hz and sampled at 0.5Hz. Minute averages were calculated and used for assessment by a trained researcher and the error-checking algorithm. For manual analysis, the researcher retrospectively reviewed the high frequency mean arterial pressure data point-by-point and removed any values that were deemed non-physiological. Artifacts were defined as values that increased or decreased rapidly (e.g., >20mmHg transient fluctuations from preceding MAP values) and returned to values similar to those preceding the large change in a short period of time or were non-physiological (e.g., negative values). The algorithm was implemented using the pre-set parameters and identified artifactual data by integrating minute-by-minute blood pressure changes as well as the relationship between the spacing of systolic, diastolic, and mean arterial pressure values over time. All analyses were performed in R version 4.1.1. Results: Arterial line blood pressure data was extracted from 16 patients over 9 months (April-December 2018). 41,093 minute-by-minute data points were reviewed manually by a trained researcher and using the algorithm. Manual review resulted in the identification of 117 (0.28%) artifacts. Meanwhile, the algorithm identified 104 (0.25%). Compared to manual review, the algorithm had a 37.6% sensitivity and 99.8% specificity using pre-set parameters for acceptable fluctuations in diastolic, systolic, and mean arterial blood pressure values. Conclusion: The error-checking algorithm had low sensitivity and high specificity in detecting arterial line blood pressure artifacts compared to manual data cleaning. Additional work is needed to optimize performance in a critical care setting including adjusting decision parameters and manual annotation of known arterial line disruptions. Given the growing use of artificial intelligence in critical care research, methods to validate the quality of high frequency data is important to optimize algorithm performance and prevent spurious associations based on artifactual data. Background: Carbon dioxide (CO2) closely regulates cerebral blood flow (CBF) and actively participates in different aspects of brain physiology such as hemodynamics, oxygenation, and metabolism [1, 2] . Reductions in arterial partial pressure of CO2 (PaCO2) and the following hypocapnia may modify the variables mentioned above and comprise secondary insults in aneurysmal subarachnoid hemorrhage (aSAH) [3] [4] [5] . Moreover, the duration of hypocapnia was independently associated with poor outcomes in aSAH. However, the current study may focus on only one abnormal value of PaCO2, and the role of dynamic changes in PaCO2 on unfavorable outcomes in aSAH has not been investigated well. Objectives: To investigate the independent effect of the dynamic changes of PaCO2 on outcome in patients with aSAH. Methods:154 consecutive patients with aSAH presenting to the Department of Intensive Care Unit (ICU), Beijing Tiantan Hospital, were retrospectively enrolled. Arterial blood gas values were measured and collected at random time intervals during the ICU treatment's first ten days. The time-weighted average (TWA)-PaCO2 was calculated by the sum of the average PaCO2 values among consecutive time points multiplied by the intervals between consecutive time points and dividing the sum by the total time. Patients were categorized into two groups (TWA-hypocapnia, TWA-PaCO2 <35 mm Hg; TWA-normocapnia, TWA-PaCO2 35-45 mm Hg). The study's primary outcome was the modified Rankin score (mRs) at three months, which was ascertained from clinic notes of routinely scheduled 3-month aneurysm clinic follow-up visits by staff blinded to the CO2 exposure status of the patient. The study's secondary outcomes were symptomatic vasospasm and delayed cerebral ischemia (DCI). Univariable and multivariable logistic regression analysis was used to assess the independent effect of TWA-hypocapnia on 3-month neurological outcomes. Results: Overall, a total of 45 (29.2%) had an unfavorable outcome at three months, who were older (mean age 50.8 vs 58.1, p < 0.001), had worse clinical status on admission: Hunt and Hess score (median 2 vs 3, p < 0.001) and Modified Fisher Score (median 3 vs 4, p < 0.001) and World Federation of Neurological Surgeons (median 2 vs 2, p < 0.001), and higher rates of the use of mechanical ventilation ( 3, 4 However, the deployment of ECPR represents a considerable logistical challenge. 4, 5 The circuit should be put in place as quickly as possible in order to reduce the time of cerebral ischemia. 4, 6 Rigorous time management is essential for the success of the technique. 7 Objectives: We aimed to establish the prehospital time in patients with OHCA transported to our center and the proportion of optimal ECPR candidates for whom the ECPR team was called. Moreover, we aimed to establish the time between patient arrival to the emergency department (ED) and ECPR team activation, the time for team arrival, the time to reach a decision concerning ECPR, as well as the time required for the initiation of extracorporeal support. The overarching goal was to help develop targeted interventions aimed at improving speed of deployment and ECPR candidacy by focusing on problematic time intervals. Methodology: We performed a single-center retrospective cohort study. We included all consecutive patients with OHCA who were transported to Hôpital du Sacré-Coeur de Montréal, between July 1, 2018, and June 30, 2021. The data was collected from electronic medical records. We defined optimal ECPR candidates as patients (1) aged 55 years old or less with a (2) witnessed arrest and (3) no return of spontaneous circulation after 20 minutes of conventional CPR, (4) arriving at the hospital within 60 minutes of the initial arrest (5) during the day (between 8:00 and 17:00). For descriptive statistics, continuous variables were presented as medians with interquartile ranges and discrete variables were presented as counts and percentages. Results: Over the 3-year study period, 427 patients were transported to our ED for OHCA, 15 of which met all of the above-mentioned criteria for ECPR (3.5%). The ECPR team was called for 7 of these optimal ECPR candidates (46%) and for 21 other patients. Of the 28 instances in which the ECPR team was activated, canulation was attempted in 10 cases (36%) and successful in 7 cases (70%). The median time for Basic Life Support (BLS) team to arrive on scene was 12 [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] Managing an open abdomen with bedside dressing changes in the ICU rather than the OR reduces patient transfers and cost. Though efficient, moving open abdomen management to the ICU has the potential to cause significant stress on the intensive care multidisciplinary team. We aim to better understand the experiences and opinions of team members after experiencing a bedside OA dressing change. Objectives: To understand the perspectives of the intensive care multidisciplinary team members regarding bedside OA dressing change in the ICU and to gain perspective regarding perceived feasibility, challenges, support, and stress associated with bedside changes. Methods: Patients were selected from individuals admitted to the ICU at the QEII Health Sciences Center, Halifax Nova Scotia who had an OA requiring management with an ABThera temporary abdominal closure device. A perioperative risk assessment was conducted and patients were deemed appropriate to undergo bedside ABThera changes within the ICU. Changes were performed as sterile procedures, in a private room, with limited traffic. Procedure carts were used to set up the sterile field immediately before the change was to occur. Once the dressing change had occurred, participants were asked to fill out a survey regarding their experience. The survey consisted of seven questions on a 5-point Likert scale (Appendix 1). Responses were recorded Results: Response rate was 100% from all members of the ICU multidisciplinary team and surgery team asked to fill out a survey. A total of thirty surveys were returned evaluating the experiences during six ABThera changes in the ICU. Surveys were collected from eleven ICU nurses, one OR nurse, one Respiratory Therapist, nine Surgery Residents, one surgery attending, one ICU resident, five ICU attendings, and one anesthesia resident. From these surveys ninety seven percent of respondents felt ABThera change was appropriate for the ICU. Eighty three percent of respondents agreed that bedside ABThera change in the ICU was as easy or much easier than changing the ABThera in the OR. Eighty three percent disagreed or strongly disagreed that ABThera change was stressful. Ninety three percent of respondents indicated that they felt Abthera change in the ICU improved or did not hinder patient care. Ninety percent of respondents agreed that changing ABthera dressings in the ICU is convenient. All respondents agreed or strongly agreed that avoiding patient transfer was beneficial for patient care and ninety seven percent of respondents support or strongly support future ABThera changes in the ICU. Importantly, two respondents felt that bedside changes were harder or much harder; however, indicated that they felt it was safe and beneficial to reduce patient transfers. Conclusion: Bedside OA dressing changes in the ICU are well received by the multidisciplinary team at our institution. They are viewed as beneficial, appropriate, safe, and efficient. Bedside dressing changes did not cause undue stress on members of the team and were seen as easy to facilitate. Introduction/Background: COVID-19 patients and others with severe respiratory failure often require proning. In response to challenges with proning COVID-19 patients, the Apparatus and Method for Moving a Patient (AMMP) was developed to improve patient and provider safety. Objectives: To evaluate use of the AMMP to prone COVID-19 patients with severe respiratory failure. Methods: In 2021, providers including physicians, nurses, and respiratory therapists working in the ICU at the QEII Health Sciences Centre (Halifax NS) participated in a clinical trial (NCT04882865) using the AMMP to prone COVID-19 patients with severe respiratory failure. Subject selection was quasi-random and included members of the healthcare team assigned to care for ICU patients. Education on proper use of the AMMP was provided prior to movements. Paper-based surveys were administered upon completion. Providers were asked to evaluate ease of use, time, safety, and any adverse events during the proning procedure. Results: Overall, a total of 57 ICU healthcare providers completed surveys after using the AMMP to prone COVID-19 patients. Most providers found it easy to apply the AMMP to the patient (91%; 52/57), adjust strap length (91%; 52/57), and remove after completing the movement (91%; 52/57). Compared to standard proning procedures, 88% (50/57) felt physical demands were reduced using the AMMP and 68% (39/57) agreed it took less time to complete prone positioning. Most providers believed the AMMP improved patient safety (89%; 51/57) and healthcare team safety (93%; 53/57), and that fewer providers were required to move patients into prone position (89%; 51/57). 81% (46/57) of respondents reported no adverse events while proning critically ill patients. Of the reported adverse events, the majority were related to pillows or padding after proning (6/10; 60%). Oxygenation desaturation by 5% was described in 3 responses (n=3), while one patient had a >20% change in heart rate or blood pressure (n=1). One incident of AMMP anchor strap malposition was reported (n=1). There were no incidents of endotracheal tube dislodgement or patient injury. Conclusion: Critically ill patients were safely proned using the AMMP. Healthcare providers concluded the AMMP improved the ease, length of time and safety of proning patients compared to their standard proning approaches. Introduction: The prevention and management of pain and agitation in critically ill children is a complex balance of risks and benefits within a developmentally diverse population. Uncontrolled pain and agitation, and exposure to sedatives, are associated with negative sequelae [1] [2] [3] [4] [5] . Despite recommendations for the use of nonpharmacological therapies, pharmacological interventions remain the foundation of pain and agitation management in pediatric critical care [6] [7] [8] [9] . The benefits of comfort holding to children and their caregivers may include decreased pain, agitation and distress, as well as the many benefits associated with early mobilization [11] [12] [13] [14] [15] [16] [17] [18] . However, despite its promise as potential therapeutic intervention, little is known about comfort holding in PICUs 10 . The objective of this study was to describe the prevalence of, and characteristics associated with, holding in PICUs in Canada. Methods: As part of the PARK-PICU study, data was collected on all children admitted to 11 PICUs in Canada for > 72 hours who received any in bed or out of bed (OOB) mobility during 2 study days in 2018. Holding was defined as being held OOB for the purposes of comfort or mobility. Descriptive statistics were presented as means (95% CI), medians [IQR] , and proportions; p-values were calculated using Pearson's chi 2 . Logistic regression was used to estimate the odds ratios (OR) of comfort holding, controlling for possible confounders. Results: Of 110 children, 70 (63.6%) were held. The majority of the children who were held (94.3%) were 0-2 years of age. The median time to being held was 17.5d (8-50) from PICU admission. Young age (0-2 y) and weight (<10kg), were independent predictors of being held; OR 30.64 (9.23-101.77, p<0.001) and 12.46 (4.86-21.94, p<0.001) respectively. This remained statistically significantly in multivariate analysis controlling for sex, pre-admission function and primary reason for admission. The adverse event rate (e.g. device dislodgement, change in vital signs) for holding was 3.8% as compared to 1.9% for all other OOB mobility (p=0.393). Children receiving invasive ventilation had lower odds of being held 0.25 (0.09-0.67, p=0.006) compared to children receiving little or no respiratory support, as did those who were physically restrained 0.15 (0.04-0.61, p=0.008). Nurse-patient ratios, the presence of invasive lines, vasoactive infusions and analago-sedative medications were not statistically significantly associated with being held. Conclusions: Comfort-holding is common in PICUs in children aged 0-2 years of age, but is rare in children >2 years of age. Invasive ventilation and a need for physical restraints are associated with lower odds of being held, but other previously identified barriers such as nurse patient ratio, presence of invasive lines, vasoactive medications, and analgesic and sedative infusions were not found to be associated with children being held. The rate of adverse events was not significantly different between children that were held and children that were not held (but still received out of bed mobility), suggesting holding is safe. This study is limited in that patients who did not receive any or patients newly admitted to the PICU (<72 hours) were excluded, therefore the rates of holding may be over reported. Comfort-holding is likely an under-utilized intervention in Canadian PICUs and further study into its benefits and safety in older children is needed to inform implementation into practice. Introduction: Medical personnel often experience stress when responding to a medical emergency. A known stress-response is a measurable reduction in heart rate variability. Heart rate variability is the beat-to-beat variation in cardiac cycle lengths (R-R interval), which is highly influenced by the autonomic nervous system. Crisis simulation is an established tool, used to expose trainees to stressful situations in a controlled and safe environment. While meant to feel realistic it is currently unknown if these simulations elicit the same stress response as real clinical emergencies. Objective: We aim to compare stress response amongst medical providers, by measuring heart rate variability in medical trainees responding to both simulated as well as real medical emergencies. We performed a single center prospective observational study, enrolling 19 resident physicians (PGY 1-5). Heart rate variability was measured using a 2-lead heart rate monitor (Bodyguard 2, Firstbeat Technologies Ltd) worn during 24-hour call shifts. Data was collected at baseline, during high-fidelity simulated medical emergencies, and during participants' response to real medical emergencies. Results: 57 observations were made to compare heart rate variability throughout the participants' critical care rotation. Each heart rate variability metric (SDNN, RMSSD, PNN50, LF, LF/HF) responded in a predictable manner when comparing changes between baseline and simulation as well as changes between baseline and response to medical emergencies (Table 1) . Statistically significant differences were observed between baseline and simulated medical emergencies in SDNN ( There were no statistically significant differences between simulated and real medical emergencies for any heart rate variability metrics. Conclusion: Simulation is a valuable tool in medical education and training. We have shown that simulation can elicit the same autonomic nervous system activation in medical trainees as actual medical emergencies. Therefore, simulation may represent a reasonable way to practice essential skills in a safe environment with realistic provider-response. Multiple aspects contribute to the realism of a simulation; heart rate variability may represent one way to assess which components of simulation are essential and may help eliminate those components that may be costly and unnecessary. Introduction: Mesenchymal stem (stromal) cells (MSCs) are multipotent cells that demonstrate therapeutic potential for the treatment of acute and chronic inflammatorymediated conditions. Especially for acute conditions, it is critical to have a readily available cryopreserved MSC product for rapid administration. Although controversial, some studies suggest that MSCs may lose their functionality with cryopreservation which could render them non-efficacious. Objectives: In comparative pre-clinical models of inflammation, to determine if there are differences in in-vivo measures of pre-clinical efficacy (primary outcomes) and invitro potency (secondary outcomes) between freshly-cultured and cryopreserved MSCs. Methods: A systematic search on OvidMEDLINE, EMBASE, BIOSIS, and Web of Science (until June 5, 2020) was conducted to identify comparative pre-clinical studies of freshly-cultured versus cryopreserved MSCs from any source in models of inflammation. Freshly-cultured MSCs were defined as cells that had been in continuous culture since extraction or cryopreserved for any duration but then cultured for more than 24 hours prior to use. The primary outcome included measures of in-vivo preclinical efficacy; secondary outcomes included measures of in-vitro MSC potency. Primary outcome domains were: 1) Organ dysfunction and composition of tissues (e.g. histopathological damage); and 2) Protein Expression and Secretion (e.g. cytokine levels, immunohistochemistry analysis). In-vitro potency outcome domains were: 1) Coculture assays; and 2) Protein Expression and Secretion. Risk of bias was assessed by the SYRCLE "Risk of Bias" assessment tool for pre-clinical studies. The majority of preclinical in-vivo outcomes and in-vitro potency outcomes (number and percentage) did not detect significant differences (p<0.05) in pre-clinical efficacy between freshly-cultured and cryopreserved MSCs. With our systematic summary of the current evidence base, we hope it may provide MSC research scientists as well as regulatory bodies additional rationale and justification for considering a cryopreserved MSC product in their clinical trials. Introduction: In mechanically ventilated patients, an abnormal respiratory drive is frequently present. Derangements in respiratory drive can result in a low or high inspiratory effort, injuring the respiratory muscles (myotrauma), or the lung (P-SILI), and negatively impacting a patient's outcome. Respiratory drive cannot be directly measured, but it can be estimated based on its output with the airway occlusion pressure (P0.1) and with electrical activity of the diaphragm (Eadi). Inspiratory effort can be assessed by maximum Eadi during tidal breathing (Eadi peak ) and changes in respiratory drive and effort correlate with changes in Eadi peak . Effective monitoring of these dynamic variables is necessary to ensure proper management of patients in the ICU, however, the relationship between P0.1 and Eadi has not been examined. Conclusion: This preliminary analysis shows that overall, there is a weak positive correlation between Eadi and P0.1, however, there is variability in the strength of the positive correlations ranging from very weak to moderately-strong in our patient sample. Future work should investigate the individual Eadi-P.01 data to assess the difference in the slopes and coefficient of variability in order to enhance our understanding of the relationship between Eadi and P.01 over a 24-hour period. Potential factors affecting these values such as sedatives, opioids, early neuromuscular blockade and differences in ventilatory settings should be examined further to elucidate the variability of the correlations between patients. Additionally, the 24-hour variability of Eadi and P0.1 should be evaluated to learn how often they should be monitored to be representative of respiratory drive and effort. Introduction: Adult critical care residency training programs across Canada transitioned to a competency-based medical education (CBME) model for trainees beginning fellowship after July 1, 2019. In this curriculum, critical care trainees undergo discrete observed encounters (EPAs) throughout fellowship ranging from procedural skills, resuscitation of critically ill patients, family dynamics, team management and completion of scholarly activities. Prior to this change, critical care fellows were assessed and evaluated through time based "blocks" or "rotations" after which a summative evaluation was provided. The shift from time-based and rotation-based evaluation has changed the types, frequency and duration of evaluation. With the implementation of objectives as part of time-based medical education, attempts were made to standardize the skills required and competencies expected from graduating fellows transitioning to early career. The shift to CBME is a further extension of this process to link resident evaluation to individual objectives and reduce the reliance on time-based broad evaluations. At present there is little known about the impact of this on resident documentation, administrative workload, perception of learning or clinical outcomes. We propose to survey the current critical care trainees to determine their perception of the competency-based medical education curriculum and its impact on fellow training, education and quality of life. Objective: We aim to characterize the experience of the first cohort to go through CBME as a way to evaluate the current status of medical education in adult critical care and identify gaps to be addressed for future cohorts. Methods: Using an iterative process, we designed a digital survey that was administered to dult critical care trainees enrolled on or after July 1,2019. Survey questions were designed to evaluate trainees perception, experience and knowledge of the CBME process. Results: A total of 33 trainees responded to the survey. 52% were in first year and 45% were in their second year of training and 33% had previously been enrolled in a CBME-based program. 25% of survey responders were in foundations of discipline, 41% in core and 10% had completed all requirements of the CBME curriculum. Challenges identified by responders include the large number of EPAs to complete, identifying and matching EPAs with key clinical opportunities, completing EPAs for high acuity rare events and staff availability for direct supervision. Rare procedures (cricothyroidotomy and pulmonary artery catheter) were identified as the most difficult EPAs to complete. Responders spent 14% of their clinical time completing, preparing or filling out EPAs with only 20% resulting in face-to-face feedback and 25% providing "valuable" feedback. Additional evaluations -rotation and weekly evaluations occurred for 93% and 52% of responders and led to specific and measurable feedback 50% of the time. Conclusion: As the implementation of CBME in adult critical care training continues, there are several areas to address with respect to the perception of trainees, developing techniques to improve efficiency and improving the perceived effectiveness of physician supervisor feedback. More work is required to help characterize this further. Cook, Deborah J Introduction: Clinical research operations for critically ill patients intensified during the pandemic, underscoring the importance of interprofessional communication, coordinated informed consent encounters and co-enrolment processes. Some preexisting non-COVID-specific randomized clinical trials (RCTs) were paused, selected RCTs were continued, and several new RCTs investigating COVID-19 treatments were initiated. The objective of this study was to analyze the consent, enrolment, and coenrolment patterns during the 1 st , 2 nd , and 3 rd wave (March 2020 -May 2021) of the COVID-19 pandemic in a university-affiliated ICU. Methods: This multi-study, single-center observational analysis was conducted at St. Joseph's Healthcare Hamilton. We examined all 12 academic RCTs in the ICU, and COVID-specific RCTs on the COVID ward. COVID-specific RCTs included CATCO, CONCOR-1, CORONA, COVI-PRONE, and LOVIT-COVID. Non-COVID-specific RCTs, some of which were operational for patients with COVID-19, included BALANCE, CYCLE, FAST, FISSH, LOVIT, REVISE, and REMAP-CAP. Data sources included screening and enrolment logs, and admission registries from March 2020 to May 2021. Reasons for no consent encounters (e.g., staff or system capacity) were not captured, nor were consent decline reasons; observational studies were not considered. Results: There were 1220 total ICU admissions in the study period, the lowest (N=55) in March 2020 at the start of the pandemic, and highest (N=94) in January 2021. The peak number of COVID-19 ICU admissions (N=42) and highest proportion of infected patients relative to total admissions (48%) occurred in April 2021. Over the 15-month study period, 5 COVID-specific RCTs were launched and 2 were completed; 2 of the 7 non-COVID-specific RCTs were paused, and 5 were continued throughout -enrolling both patients with or without COVID (BALANCE-ICU, FISSH, LOVIT, REMAP-CAP, and REVISE). Overall, 165 patients contributed to 215 enrollments into at least one RCT and peaked with 35 enrollments in March 2021. COVID-specific RCT enrollment peaked at 24 in March and April 2021. There were 215 enrolments in total, in the following RCTs: REVISE 56 (26%), CATCO 36 (17%), COVI-PRONE 33 (15%), LOVIT-COVID 27 (13%), LOVIT 22 (10%), FISSH 9 (4%), CONCOR-1 9 (4%), REMAP-CAP 7 (3%), BALANCE-ICU 6 (3%), CORONA 5 (2%), CYCLE 4 (2%), and FAST 1 (<1%). Co-enrollment in 2 or more RCTs occurred in 45 patients and was most frequent in March 2021. The overall informed consent rate for all RCTs (proportion agreed of those eligible and approached) was 64% (215 of 338); the informed consent rate was 50% for COVID-specific RCTs (110 of 221) and 90% for non-COVID-specific trials (105 of 117). CYCLE, FISSH, FAST, REMAP-CAP, and LOVIT-COVID had 100% consent rates. Conclusions: The importance of continuing clinical trials in the ICU was underscored during the pandemic, along with the imperative to generate new evidence to treat patients with COVID-19. Some pre-existing RCTs were paused while others were pursued during the first 3 pandemic waves; meanwhile, 5 COVID-specific trials were launched and 2 were completed. Though consent rates varied across studies, and between patients with and without COVID-19, co-enrolment was common. Hassine, Chatila Hadj Background: Patients recovering from critical illness have usually been discharged home after a period of transition on the hospital ward. Discharge directly home (DDH) has been initially described in adult patients suffering from a terminal illness and therefore were directly discharged home to facilitate palliative care and death (1, 2) . Nevertheless, recent adult data show that DDH is becoming a more and more common practice, due to decreasing beds availability. There are, to our knowledge, no studies describing the practice of DDH in pediatric patients. Objective: To describe the incidence and the characteristics of pediatric patients discharged directly home from a single pediatric intensive care unit (PICU). Methods: We conducted a retrospective descriptive study of all pediatric patients, admitted between January 1st 2014 to January 1st 2020 to the critical care unit of CHU Sainte-Justine. We included all patients < 18 years of age, who survived their PICU stay and were discharged directly home or to an inpatient ward. We excluded patients who were transferred to other hospitals or care facilities. Patients discharged directly home were compared to patients discharged to the ward using descriptive statistics, and logistic regression was used to identify factors associated with home discharge. Results: Among the 5531 patients included in the study, 594 (10,7%) were discharged directly home from the PICU. Of these, 363 (61,6%) were males, and the median age was 36 months (IQR 15-108). The proportion of patients discharged directly to home increased from 5% (of all survivors) in 2014 to 14% in 2019. Compared to patients transferred to a pediatric ward before discharge, patients discharged directly home were older (p<0.001), were less severely ill (p<0.0001), less ventilated (<0.001), and had shorter PICU stay (p<0.0001). Patients discharged directly home had also significantly less total hospital stay (p<0.0001) . The three most frequent admission diagnoses for patients discharged directly home were respiratory acute distress (31%), acute intoxication (18,6%), and ENT postoperative care (12,5%). Conclusions: There is an increasing trend to discharge critically ill pediatric patients directly at home in our PICU. The patients discharged directly home were older, less severely ill, were less ventilated, and had a shorter length of stay in the ICU. Tests of association between home discharge and ICU/ ward census are ongoing, as well as the evaluation of the incidence of readmission. Background: Although children admitted directly from the Emergency Department (ED) account for a large proportion of admissions to the Pediatric Intensive Care Unit (PICU), little is known about how many children in ED are considered for admission to the PICU and clinical trajectories after consultation that does not result in PICU admission. Disposition decisions are often difficult when patients are perceived to be "too well" to benefit from PICU despite being "too sick" for under resourced inpatient wards (1, 2) . Although prior studies in adults demonstrate acceptable short-term outcomes for patients considered for, but not admitted to, medical intensive care units, clinical and process-based outcomes have not been previously studied in children (3). Objectives: This study aimed to describe the characteristics and short-term outcomes of children who had a PICU consult in the ED that did not result in direct admission to the PICU. Methods: This retrospective cohort study was conducted at a pediatric hospital in Canada. All children (<18 years) who had a PICU consult in the ED between January 1 and December 31, 2019 and were admitted to the PICU or general inpatient ward were eligible for inclusion. Chart reviews were conducted to determine patient characteristics, elements of ED stay, and Medical Emergency Team (MET) utilization within 24 hours of ward admission. Results: Of 247 PICU consults requested by the ED, 86 (35%) resulted in ward admission (median age 44 months; IQR 15-130). Patients with respiratory conditions accounted for 54% of all consults, with lower respiratory tract infection the most prevalent reason for PICU admission (47% vs 22% ward admissions) and asthma the most prevalent reason for ward admission (29% vs 9% PICU admissions). Compared to PICU admissions, ward admissions had a longer total time in ED (median 800 minutes; IQR 552-975 vs. median 358 minutes; IQR 232-524) with longer times from triage to PICU consult (median 283 minutes; IQR 179-414 vs. median 191 minutes; IQR 102-288), as well as consult to admission (median 427 minutes; IQR 240-647 vs. median 130 minutes; IQR 80-221). During the first 24 hours of ward admission, 16 (19%) patients were reviewed by the MET (9 planned follow-up from ED, 7 new activations) with only 1 patient requiring transfer to PICU. Conclusions: In our centre, a large proportion of children who had a PICU consult in the ED were denied PICU admission and remained stable on the ward during the first 24 hours of hospitalization. High rates of MET utilization indicate that there exists a cohort of patients who may benefit from an intermediate level of care for closer monitoring. Furthermore, lengthy ED times for children considered for, but not admitted to the PICU suggests that many patients require stabilization before they can be safely transferred to the ward. Future research is required to explore benefits to provision of care in intermediate care units, including safety, cost-effectiveness, and patient-oriented outcomes. Introduction: Venovenous extracorporeal membrane oxygenation (VV-ECMO) is increasingly being used as a treatment modality for patients with severe acute respiratory distress syndrome (ARDS) (1). Saskatchewan's geography and distribution of 1.2 million residents over 651,900 km² create challenges for ECMO service concentration. The goal of this study was to identify local VV-ECMO volume anticipated at our tertiary centre, Regina General Hospital (RGH). Objectives: The objectives of this study were to identify the number of severe ARDS patients who were eligible for VV-ECMO and to evaluate the clinical outcomes of ARDS patients eligible to receive VV-ECMO. Methods: We retrospectively studied 415 consecutive intensive care unit (ICU) admissions with ARDS to RGH from October 16, 2018 to January 21, 2021. RGH is an ECMO-capable tertiary care ICU with a catchment of greater than 500,000 residents. VV-ECMO eligibility was assessed using predefined selection criteria and contraindications from the Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Syndrome trial (EOLIA), the Extracorporeal Life Support Organization (ELSO), New South Wales (NSW), and Critical Care Services Ontario (CCSO). We compared categorical data using 2 or Fisher's exact tests, and continuous data with Ttest or Wilcoxon rank-sum test depending on normality of data when appropriate. Results: Of 415 patients, 165 (40%) were female, 104 (25%) were admitted with bacterial pneumonia, 68 (16%) with aspiration pneumonia and 48 (12%) with COVID-19. For the cohort, the median age was 61 (interquartile range 46-71), sequential organ assessment score was 7 (5-9) and Charlson comorbidity index was 1 (1-3). Of the cohort, 72 (17%) received neuromuscular blockade, 58 (14%) received prone positioning, and 11 (2.7%) received inhaled nitric oxide (iNO). Ventilator settings demonstrated a median set tidal volume of 7.8 ml/kg of predicted body weight (7. [1] . Due to their safety profile, IVFs were long not considered "drugs" [1] , however recently that view has changed and they are now viewed as drugs. Overuse of IVFs can lead to volume overload, which can impact several organs and increase mortality [1, 2] . Conversely, fluid restriction is associated with fewer complications and reduced hospital stay [3] [4] [5] [6] . Despite significant advances made in the resuscitation of critically ill patients, the optimal dose and type of IVF to use remains unknown [7] . IVFs are delivered using infusion pump systems, controlling rate and volume. Our institution recently replaced their infusion pumps allowing for more concentrated medications to be delivered. The objectives of this cohort study was to assess IVF administration patterns and the impact of using higher concentrated medications on the amount of fluids critical ill patients received. Methods: All critically ill patients admitted to the medical/surgical ICUs in Halifax during the study period were included. Evaluation of fluid management occurred over two three-month periods, before and after the implementation of the new infusion pumps. The primary parameters assessed included volumes of maintenance, medications, nutritional and resuscitation fluids. Fluid outputs were also assessed. Data was analysed using t-test and two-way ANOVA. Statistical significance was achieved with p <0.05. Data was reported as mean ± standard error. Results: Our results show that the mean volume of intravenous medications administered was significantly decreased after the transition to new infusion pumps, when compared to before pump implementation (340.8 ± 9.1 vs. 534.7 ± 11.3 mL; p < 0.05). Conversely, the mean volume of intravenous maintenance fluid delivered was significantly increased after the implementation of new infusion pumps in comparison to older infusion pumps (554 ± 16.2 vs. 427.3 ± 11.2 mL; p < 0.05). In assessing all forms of intravenous fluid administered, only the mean volume of crystalloid fluids delivered was significantly decreased after transitioning to the new infusion pumps when compared to before pump implementation (1181.5 ± 85.6 vs. 2642.1 ± 279.6 mL; p < 0.05). Nutritional fluids did not differ between the groups. Mean urine output volume was significantly decreased in patients after the implementation of new infusion pumps when compared to before pump implementation (1076.5 ± 21.7 vs. 1409.5 ± 52.8 mL; p < 0.05). Total fluid administration was a significantly decreased in mean volume delivered after the transition to new infusion pumps in comparison to the older pumps (1597.9 ± 34.9 vs. 1914.8 ± 53.9 mL; p < 0.05). Additionally, mean volumes of total fluid output were also significantly decreased after transitioning to new infusion pumps in comparison to the before pump period (1315 ± 29.6 vs. 1681.6 ± 53.4 mL; p < 0.05), with renal replacement rates being constant. Conclusion: Overall, our findings show that implementation of new infusion pumps that allow for delivery of highly concentrated medications resulted in a significant decrease in overall fluid administration to critically ill patients. Introduction/Background: Proning critically ill patients presents risk to both patient and healthcare provider. In response to challenges with proning COVID-19 patients, the Apparatus and Method for Moving a Patient (AMMP) device was developed to facilitate the proning of patients while minimizing risk to the patient or the healthcare team. Objectives: Using healthy participants as patient volunteers, this study sought to determine if the AMMP makes it easier, quicker, and safer to prone patients compared to using the standard approach. Methods: In this preclinical feasibility study, healthy participants were recruited to participate as patient volunteers at 2 ICUs in Nova Scotia (QEII Health Sciences Centre, Cape Breton Regional Hospital). Education on how to use the AMMP was provided prior to performing the movements. Healthcare providers in the ICUs including physicians, nurses, and respiratory therapists used the AMMP to move participants from supine to prone and vice versa, up/down and/or to lateral position. Paper-based surveys were administered to patient volunteers and healthcare providers upon completion of the movements. Results: In all, 10 patient volunteers and 23 healthcare providers completed surveys. The majority of volunteers were aged 18-35 years (7/10; 70%) and weighed 61-90kg (6/10; 60%). None of the volunteers reported being injured while being repositioned using the AMMP, and none of the providers reported any strain or injury to a volunteer or to a team member. Among providers, 91.3% (21/23) felt the AMMP was easy to apply to patients, 100% (23/23) found it easy to adjust strap length, and 100% (23/23) found it was easy to remove after the movement was completed. Compared to prone positioning using the standard approach, 100% (23/23) providers felt that using the AMMP was safer for the healthcare team and 96% (22/23) felt it was safer for the patient. All providers (23/23; 100%) agreed physical demands were reduced using the AMMP, and 96% (22/23) agreed it took less time to complete prone positioning and required fewer providers to prone and reposition the patient volunteers. Conclusion: Volunteers felt comfortable and secure being proned and repositioned in the AMMP. Healthcare providers in the ICU found the AMMP easier to use and less physically demanding compared to their standard approach to proning. (1) . Since then, the world has been inundated with thousands of critically ill patients, many of whom develop acute respiratory failure requiring admission to an intensive care unit (ICU). Ontario is now in its fourth wave of COVID-19. During the first three waves, hospitals have needed to expand ICU capacity and implement novel strategies to manage growing numbers of acutely ill patients. The use of high-flow nasal cannula therapy (HFNC) is a potentially effective non-invasive oxygenation strategy to support COVID-19 patients with severe respiratory failure. In Ontario, there is no standardized approach to its use in hospitals. In our institution, we have implemented a nursing-and respiratory therapist-championed initiative to support patients on HFNC on the general medical ward in an effort to preserve capacity in ICU. Methods: We performed a retrospective review of patients admitted to hospital with a diagnosis of COVID-19 and supported by HFNC on the medical ward from April 2020 -June 2021. We described the baseline characteristics of these patients and the hospital outcomes. We performed structured interviews of allied health professionals who were involved in championing the HFNC ward program and who actively managed these patients. A modified Delphi approach was used to develop educational materials for teaching, safety and continued quality improvement. A total of 346 patients with COVID-19 pneumonia were managed with HFNC on the general medical ward at our institution. Allied health professionals 4 allied health professionals were interviewed regarding their experience managing COVID-19 patients with severe respiratory failure supported by HFNC on the medical wards. Summarized themes and answers are detailed in Table 1 . All participants identified challenges with managing acutely ill patients on a medical ward but also recognized learning opportunities. All participants felt more comfortable managing HFNC post waves 1-3 compared to pre-pandemic. Stakeholders identified and created the following educational materials: principles of oxygen administration, HFNC anatomy and physiology, CCRT activation process, principles of self-prone positioning, Hamilton T-1 and Phillips V6 ventilator setup and alarm guide, anatomical airway assessment (Figure 1) . Conclusion: Novel approaches to the delivery of care to critically-ill patients are required to maintain ICU capacity and expand clinicians' abilities to care for an increasingly large number of patients with acute care needs. Allied health professionals believe that the expansion of ICU-level care to the medical ward has important challenges but presents unique opportunities to deliver patient-centered, high-quality critical care to severely affected COVID-19 patients. Our experience with HFNC offers unique insights to other institutions and policy makers for protocols and policies for care amidst an evolving fourth wave of COVID-19. Introduction The burden of dialysis-requiring acute kidney injury (AKI) is rising, particularly among critically ill adults 1, 2 . Long-term kidney replacement therapy (KRT) and critical illness have been independently linked to prolonged cognitive impairment 3 and structural brain pathology [4] [5] [6] [7] , and adults on short-term KRT in the ICU may be at risk for superimposed impairments. Delirium is one of the most consistent risk factors for cognitive impairment among critically ill adults, and has been associated with degree of brain atrophy 6 . Regional cerebral oxygenation (rSO2) predicts delirium in critically ill adults 8, 9 , and may provide an early marker of cognitive impairment in patients treated with KRT in the ICU. No longitudinal studies have examined the relationship between KRT, delirium, and long-term structural and cognitive outcomes in critically ill patients. Objectives The overall objectives for this program of research are 1) to determine the association between intradialytic rSO2 and delirium, and 2) to evaluate the long-term consequences of intradialytic rSO2 following ICU discharge. Prior to embarking on the full study, we assessed feasibility through an initial 6-month pilot. We describe here the results of the pilot study. Methods This was a prospective observational pilot study of patients admitted to the Kingston Health Sciences Centre ICU between Feb-Aug 2021. Inclusion: 18 years of age, admitted to ICU, severe AKI requiring KRT, within 12h of initiation of KRT. Exclusion: history of neurological disorders, contraindication to testing, KRT via peritoneal dialysis, life expectancy <24h, renal obstruction, rapidly progressive glomerulonephritis or interstitial nephritis, or pre-hospitalization estimated glomerular filtration rate (eGFR) <30 mL/min/1.73m 2 . Participants underwent continuous rSO2 monitoring for the first 72h of continuous KRT (CKRT), and continuously during intermittent hemodialysis (iHD). Daily delirium screening was performed using the Confusion Assessment Method (CAM-ICU-7). Cognitive and neurological outcomes were assessed at 3-months post-ICU discharge using the robotic Kinarm Standard Tests™ and Repeatable Battery for the Assessment of Neuropsychological Status. days on iHD). Three participants subsequently died in ICU, one died two months after discharge, and one declined follow-up. For all participants, continuous vitals, cerebral oximetry (91.3% data captured), daily delirium screening (no missing data), and medical record review (no missing data) were successfully completed. Fig. 1 shows feasibility data on the first patient. One participant has completed 3-month follow-up testing (no missing data). Conclusion Our initial work demonstrates the feasibility of this study for the primary aim. However, the high mortality rate in ICU is a barrier to long-term follow-up data collection. This project will ultimately provide crucial insight into the early neurological changes occurring in patients initiated on KRT in the ICU, and their potential impact on cognition and brain pathology. 1,2 Long-term use of antipsychotic medications is associated with increased risk of sudden cardiac death, falls, and worsening cognitive impairment. [5] [6] [7] The impact of ongoing antipsychotic medication prescriptions at hospital discharge on health resource utilization and new additional prescriptions of psychoactive medications such as benzodiazepines and opioids has not been evaluated in the hospital or post-hospital discharge setting. Objectives: We aimed to estimate health resource utilization and the odds of new prescriptions of benzodiazepines and opioids up to 1-year post-hospital discharge in critically ill patients admitted to the ICU with new typical and atypical antipsychotic medication prescriptions at hospital discharge. Methods: We completed a multi-center, propensity-score matched, population-based retrospective cohort study of adult patients admitted to one of four medical-surgical ICUs from January 1, 2014 to June 30, 2016. New antipsychotic medication prescriptions at time of hospital discharge were measured as the administration of at least one dose of antipsychotic medication during ICU or hospital admission and filled a prescription for an antipsychotic medication up to 1-year following hospital discharge. The primary outcome was a composite outcome of health resource utilization including ICU and hospital readmission, subsequent emergency room visitation, or mortality. The secondary outcome was the new prescription of benzodiazepines and/or opioids during hospitalization and up to 1-year post-hospital discharge. Results: There were 1,388 propensity-score matched patients who received and did not receive an antipsychotic medication who survived to hospital discharge. Of the ICU patients that received an antipsychotic medication in the ICU and survived to hospital discharge, 132 (21.0%) patients were continued on an antipsychotic medication at hospital discharge. The most common antipsychotic medication continued at hospital discharge was quetiapine (91 (14.5%)) and olanzapine (32 (5.1%)). New antipsychotic medication prescriptions were not associated with increased 72-hour ICU readmission, 30-day hospital readmission, 30-day emergency room visitation, or 30-day mortality. Among critically ill patients that received an antipsychotic medication during their hospitalization, there was an increased odds of additional in-hospital prescription of benzodiazepines ( Zhu, Ning Background: Spontaneous hyperventilation (SHV) is a common pathophysiological phenomenon in acute brain injury characterized by hypocapnia and is associated with poor outcomes. However, little is known about the incidence and prognosis of SHV in severe traumatic brain injury (sTBI), especially in the Chinese population. Objectives: This study investigates the incidence of SHV in sTBI and its impact on the prognosis at hospital discharge. Methods: All of the sTBI patients admitted in the intensive care unit (ICU) of Beijing Tiantan Hospital between October 2018 and December 2020 were screened retrospectively. The blood gas analysis results were collected. We define the SHV as at least one blood gas analysis result fulfilling pH > 7.45 and PaCO2 < 35 mmHg, while respiratory rate > 16 breaths/min, regardless of the methods and the modes of ventilatory support. Patients with no blood gas analysis results were excluded. We extracted the patient's characteristics and outcomes from the electrical medical records. A multivariate binary logistic regression model was used to examine the relationship between SHV and unfavorable outcome (defined as an extended Glasgow Outcome Scale between 1 and 4) at hospital discharge. Results: During the 26 months, a total of 238 sTBI patients admitted in the ICU, and 162 of them fulfill the inclusion and exclusion criteria. The overall incidence of SHV was 56.8% (moderate-SHV 35.2%; severe-SHV 21.6%). There were no significant differences between SHV and non-SHV patients in terms of injury severity score (26 [25] [26] [27] [28] [29] [30] vs. 26 [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] Conclusion: There was a high prevalence of SHV in Chinese sTBI patients. However, we did not find a significant correlation between SHV and unfavorable outcomes at hospital discharge. Introduction Accurate assessment of volume status is essential in the care of acutely ill patients. Determination of hypervolemia or hypovolemia at the bedside allows physicians to rapidly implement appropriate therapeutic measures. Existing diagnostic tools are expensive and/or unreliable for assessing volume status, while bedside exam and laboratory tests have similar limitations. 1 Static hemodynamic measurements obtained via central venous or Swan-Ganz catheters are poorly correlated with improved cardiac indices following fluid resuscitation and require invasive procedures. 1 Cheap, non-invasive and reliable diagnostic modalities are needed to inform volume status assessment in acutely ill patients. Objective To summarize the diagnostic accuracy of internal jugular vein ultrasound (IJV-US) in assessing hypervolemia and hypovolemia in acutely ill adults. Methods We searched PUBMED, EMBASE, CENTRAL, and Web of Science from database inception to June 2021. We included English language studies reporting the diagnostic accuracy of IJV-US for hypovolemia and/or hypervolemia in medically unwell adults assessed in the acute care setting using any reference standard. Two reviewers independently extracted data and assessed study quality using the QUADAS-2 tool. When multiple methods of measuring IJV-US were reported, we used the method with the best reported area under the receiver operating curve. We pooled sensitivity and specificity separately for hypovolemia and hypervolemia using bivariate random-effects models. We examined the following subgroups using meta-regression: type of ultrasound measurement; reference standard; intubation status, diagnosis of sepsis (for hypervolemia); volume responsiveness testing (for hypovolemia). We assessed certainty in pooled estimates using GRADE. (Figure 2 ). For hypovolemia, diagnostic test accuracy was better using collapsibility indices (sensitivity 0.85, 95% CI 0.80 to 0.89; specificity 0.78, 95% CI 0.64 to 0.88) compared to static measurements (sensitivity 0.73, 95% CI 0.60 to 0.82; specificity 0.70, 95% CI 0.48 to 0.86). We did not find any other subgroup effects. Conclusion IJV-US may be a useful bedside diagnostic tool for the diagnosis of both hypervolemia and hypovolemia. Randomized controlled trials examining the use of this tool in guiding therapeutic fluid status interventions are needed. We would like to thank the Canadian Society of Internal Medicine for supporting the study through the CSIM Research and Education Innovation Fund. in January 2020 1 -2 . A number of studies in the past have outlined the social, emotional and psychological impact of healthcare workers providing direct care to patients during previous infectious disease outbreaks and other natural disasters but few have focused directly on critical care nurses [3] [4] [5] [6] [7] [8] [9] . Studies conducted during this current pandemic have found high levels of stress, depression and symptoms of PTSD among healthcare workers [10] [11] [12] [13] . This study examined the impact of the pandemic on Canadian Critical Care Nurses (CCNs) in spring 2021. Objectives: Focusing on Canadian CCNs, the objectives of this study were to examine: (1) what the impact of the pandemic was on their mental health; (2) what impact the COVID-19 pandemic had on their quality of work life; and, (3) what impact the pandemic had on their intent to stay in their current positions. Methods: The study used a quantitative survey design utilizing four validated tools: 1) the impact of event scale -revised (IES-R) 14 , 2) the depression, anxiety, and stress scale (DASS-21) 15 , 3) the professional quality of life scale (PROQoL) 16 , and 4) intent to turnover tool. The study also included one opened ended free text question "is there anything else you would like to add?" Results: 425 participants responded from across Canada. 74.4% of participants reported some level of PTSD symptoms, 69.6% reported depression symptoms, 56.9% reported anxiety symptoms, and 60.7% reported stress symptoms. 100% of participants reported moderate to high burnout, and 87.1% were suffering from signs of secondary traumatic stress. When asked about their intent to leave, 44% were thinking of quitting, and 23.3% are actively searching for a new job. When given the option of adding any further comments, an overwhelming number of participants responded. The themes that emerged from the qualitative data included: 1) failed leadership at all levels, 2) the traumatic nature of their work during the pandemic and the resulting poor mental health they were experiencing, and 3) a sense of disillusionment and defeat. These themes were woven with despair and anger at the situation and the system. The overall findings of the study provide evidence of the significant negative impact the COVID-19 pandemic has had on Canadian CCN's mental health and well-being. Introduction: Health care provider (HCP) burnout and moral distress are recognized issues in critical care. The challenges faced by the COVID-19 pandemic have further heightened concern for HCP wellbeing. The pandemic has also provided opportunity to prioritize reach out and help our community cope. Psychological First Aid (PFA) is an evidence-informed approach for psychosocial support developed in 2006 by a section of the United States Department of Veterans Affairs. It has been widely endorsed by numerous groups, including World Health Organization (WHO). Alberta Health Services (AHS) has adopted PFA and utilizes the WHO model. Objectives: We aimed to adapt the WHO model for PFA for critical care, implement on a provincial scale through the Critical Care Strategic Clinal NetworkTM (CC SCN) and provide opportunities for critical care HCP to engage in and further strengthen naturally existing peer supports during the COVID-19 pandemic. Methods: The CC SCN is a provincial network of 21 intensive care units (ICU) that provide population-based care for all critically ill patients in the province of Alberta (14 adult medical-surgical ICUs, 2 cardiovascular surgical ICUs, 1 burn ICU, 1 neurosciences ICU, 3 pediatric ICUs). It has played a central role in the health system preparation and response to the COVID-19 pandemic. Embedded within the CC SCN, practice leads provide the 'frontline' perspective through unique background experiences in clinical critical care settings. Their intimate knowledge of 'what it's like on the ground' and how education is received enhanced their ability to create a unique critical care specific PFA provider course readily accessible for frontline HCP. It includes a 90-minute teaching and experience sharing session, with time for conversation, questions and feedback. The training focuses on the 5 essential elements for effective psychosocial responses, key PFA action principles, and a specific focus on responder self-care. Scenarios were created to reflect the lived experience of working in critical care environments during the strain of the COVID-19 pandemic, combined with interactive sessions that encourage conversation and reflection. A survey was sent out to PFA attendees to gain an understanding of the current work environment, how common stressors are impacting staff, and the effectiveness of PFA. Results: To date, 503 members of Alberta's Critical Care community have registered in one of 15 PFA sessions. There was engagement from all 5 zones in Alberta and broad representation of all HCP. Sessions occurred between April 20, 2020 and April 15, 2021. Preliminary survey response rate was 20%. Respondents identified that participation in PFA was to primarily support their teams and to further support their own wellbeing. The majority of respondents found PFA to be a moderately to very effective strategy to support critical care HCP. Moral distress and emotional exhaustion were identified as common themes in critical care settings during the pandemic. Conclusion: Enabling front-line critical care HCP with support through Psychological First Aid has shown broad uptake and perceived value within the critical care community across Alberta. PFA may represent a piece of the larger puzzle and part of a broader strategy to support critical care HCP and address the growing issue of burnout in critical care. PFA has created a foundation from which we can build a longer term more robust frame for supporting critical care staff. Further evaluation of PFA beyond the COVID-19 pandemic appears justified. Introduction: Sepsis is the body's reaction to an infection that often causes lasting organ injury due to a dysregulated inflammatory response and accounts for approximately 20% of all global causes of death. Currently, there are no effective treatments to reduce inflammation during sepsis and thus assist in preventing the lasting inflammation-mediated damage 1 . As a result, many patients who recover from sepsis endure permanent damage to many organ systems which make them more susceptible to future injury that likely affects them more severely 2 . Thus, therapeutic strategies to reduce the inflammatory response in sepsis are needed to save lives and improve the quality of life of those who survive sepsis. Herein, we tested the efficacy of ketone therapy that increases circulating ketones via ketone ester supplementation. Ketones are small molecules that are normally produced by the liver and are elevated during carbohydrate-deprived states, such as prolonged fasting. While ketones are classically known to be a metabolic source of energy, they also have non-metabolic effects, such as inhibiting inflammation, which can be of therapeutic importance 3, 4 . We hypothesized that ketones have potent anti-inflammatory effects in a mouse model of lipopolysaccharide (LPS)-induced sepsis and that ketones can be used to mitigate the inflammation-mediated organ damage. Objective: To determine if ketone supplementation can effectively reduce systemic inflammation and organ damage in a model of LPS-induced sepsis. Methods: We treated 8week-old mice with vehicle or a clinically tested ketone ester (KE) by oral administration for 3 days. On the third day, we injected mice with saline or 10 mg/kg lipopolysaccharide (LPS) to induce systemic inflammation and organ damage, as established previously 5 . Mice were euthanized 24 hours post-injection and the effects on systemic inflammation and organs were analyzed from the 3 groups (control, LPS, LPS+KE). In other cohorts, cardiac function was assessed 24 hours post-injection. Results: LPS-treated septic mice had a lower body weight relative to the controls, which was not altered by KE-treatment. Interestingly, LPS-treated mice had higher blood ketones compared to controls, suggesting that ketones may be important as an innate defense mechanism. Additionally, this elevation in circulating ketones was further augmented in KE-treated septic mice. While LPS-treated mice had an induction of systemic pro-inflammatory cytokines such as interferon-, IL-1B, IL-6, and CCL4, these cytokines were significantly lower in KE-treated septic mice. Similarly, LPS induced numerous inflammatory markers in the kidney, heart, and liver, a large majority of which were reduced in the KE-treated septic mice. LPS-induced renal fibrosis and cardiac dysfunction was also significantly lower in KE-treated septic mice. Finally, there was either no change or a reduction of ketolytic enzymes in various organs, suggesting that these protective and anti-inflammatory effects occur independent of ketone catabolism for energy production. Conclusion: Together, these data are the first to show that ketone therapy may be a novel approach to reducing systemic and organ inflammation and subsequent organ damage in a model of LPS-induced sepsis, and that these effects are seemingly independent of ketone catabolism. Introduction: Metabolic predictors and potential mediators of survival in sepsis have been incompletely characterized, potentially in part due to limitations of conventional statistical approaches in small cohorts. Objectives: We examined whether machine learning (ML) tools applied to the human plasma metabolome could consistently identify and prioritize metabolites implicated in sepsis survivorship, and whether these methods improved upon conventional statistical approaches. Methods: Plasma gas chromatography-liquid chromatography mass spectrometry quantified 411 metabolites measured 72 hours of ICU admission in 60 patients with sepsis at a single center (Brigham and Women's Hospital, Boston, USA). Seven ML approaches were trained to differentiate survivors from non-survivors. Model performance predicting 28-day mortality was assessed through internal crossvalidation, and innate top feature (metabolite) selection and rankings were compared across the 7 ML approaches and with conventional statistical methods (logistic regression). Metabolites were consensus ranked by a summary, ensemble ML ranking procedure weighing their contribution to mortality risk prediction across multiple ML models. Results: Median (IQR) patient age was 58 (47, 62) years, 45% were women, and median (IQR) SOFA score was 9 (6, 12) . Mortality at 28 days was 42%. Models specificity ranged from 0.619 to 0.821. Partial least squares regression-discriminant analysis and nearest shrunken centroids prioritized the greatest number of metabolites identified by at least one other method. Penalized logistic regression demonstrated topfeature results that were consistent with many ML methods. Across the plasma metabolome, the 13 metabolites with the strongest linkage to mortality defined through an ensemble ML importance score included lactate, bilirubin, kynurenine, glycochenodeoxycholate, phenylalanine, and others. Four of these top 13 metabolites (3-hydroxyisobutyrate, indoleacetate, fucose, and glycolithocholate sulfate) have not been previously associated with sepsis survival. Many of the prioritized metabolites are constituents of the tryptophan, pyruvate, phenylalanine, pentose phosphate, and bile acid pathways. Conclusion: We identified metabolites linked with sepsis survival, some confirming prior observations, and others representing new associations. The application of ensemble feature-ranking tools innate to ML to metabolomic data may represent a promising statistical platform to support biologic target discovery. The metabolomics analysis was funded by an NIH/NHLBI grant (1 R01 HL112747-01). /L and a new diagnosis of AML were included. Their clinical and laboratory data was evaluated across their first 5 days of hyperleukocytosis. Our primary outcome was ICU admission and our secondary outcome was 60 day mortality. Results: One-hundred and sixty-nine patients were admitted with a diagnosis of AML and hyperleukocytosis. Mean age was 58 (SD 15) and 59% were male with 43% having greater than 2 comorbidities. Median WBC on the first day of hyperleukocytosis was 103 (IQR 67-152), with 55% having a WBC >100 and 15% having a WBC >200. On the first day of hyperleukocytosis, 63% had hypoxemic respiratory failure, 25% (43) had biochemical tumor lysis syndrome, and 49% were diagnosed with acute kidney injury (8% requiring dialysis) ( Table 1) . ICU admission was required in 44% of the cohort admitted and the median time to ICU was 1 (IQR 0-3) days. Across entire cohort, median change in from day 1 to 2 was -17 (IQR -31 --1), the median greatest decrease in WBC over a 24 hour period was 58 . Drop in WBC in first 5 days was higher in those not admitted to ICU and across survivors. (Table 1 ). Across the ICU cohort, 59% required invasive mechanical ventilation, 76% had acute kidney injury and 48% require vasopressors ( Table 2 ). Across those admitted to the ICU, 81% were admitted within 4 days of hyperleukocytosis. Sixty-day mortality across the whole cohort was 30% (57% across the ICU cohort and 8% across the non-ICU exposed). ICU mortality was 82% across those who required invasive mechanical ventilation during the first 5 days of hyperleukocytosis. Hospital admission factors associated with ICU admission included hypoxia on day 1 of hyperleukocytosis (PaO2/FiO2 OR 0.97 (95% CI 0.96-0.98, p<0.001) and acute kidney injury (OR 12.2 95% CI 1.8-83, p 0.011) ( Table 4 ). Factors associated with 60 day mortality included male sex, WBC >100, lower PaO2/FiO2, any invasive mechanical ventilation and a lower drop over a 24 hour period in the WBC across the first 5 days. Conclusions: The vast majority of patients with hyperleukocytosis were managed on the inpatient wards and had a mortality rate of 8%; however, the subset admitted to ICU and particularly requiring invasive mechanical ventilation on admission did poorly. Background: Few Canadian community intensive care units (ICUs) participate in clinical research, although community hospitals hold over two-thirds of Canadian hospital beds. Study recruitment in community ICUs could accelerate the pace of knowledge acquisition, improve the generalizability of study results, research equity, and accelerate knowledge translation. Objectives: The objective of this study was to examine the motivating factors, barriers and facilitators to research participation amongst Canadian community ICU stakeholders. Methods: A cross-sectional online survey was distributed between May and November 2020. The survey focused on 6 domains: participant demographics, ICU characteristics, ICU research infrastructure, motivating factors, perceived barriers, and perceived facilitators. Participants were also asked to evaluate possible research funding models including (A) a partial subsidy for an in-house research coordinator (RC) with study payments going to the ICU, (B) a complete subsidy for an off-site RC for one specific study with study payments reverting to the external sponsor, (C) inhouse RC hired by external sponsor for a package of studies with study payments reverting to the study sponsors. Results: Responses were received from 73 Canadian community ICU stakeholders, representing 18 ICUs. Participants rated their interest in participating in pandemic research at 5.2 ± 1.9 (mean ± standard deviation [SD]) on a 7-point Likert scale from 'not interested' to 'very interested'. The strongest motivating factor for research participation was research improves clinical care and outcomes. The most significant facilitators of research involvement were the availability of an experienced RC and dedicated external funding to provide start-up costs for a research program, while the most significant barriers to research involvement were a lack of start-up funding for a RC and a lack of ICU research experience. With respect to research infrastructure, 7/18 ICUs had a pre-existing clinical research program and 6/18 had access to a research coordinator. Most participants preferred research funding model A, in which the ICU would receive a partial subsidy for a RC salary and retain local control over their research program. Conclusion: Canadian Community ICU stakeholders are interested in participating in pandemic research but lack basic infrastructure, research personnel, research experience and start-up funding. Evolution of a research support model at community hospitals, where most patients receive acute care, may increase research participation and enhance the generalizability of funded research. Introduction/Background: Hyperammonemia is a metabolic condition defined as an increase in the level of ammonia in the blood. As ammonia is a neurotoxin, hyperammonemia can present with cognitive symptoms and reduced level of consciousness. The most common cause of hyperammonemia is liver cirrhosis, and non-hepatic hyperammonemia in adults is rare. Objectives: To report a unique case of non-hepatic hyperammonemia, review relevant literature, and discuss potential causes. Methods: We report a unique case of hyperammonemia following a complicated clinical course of aplastic anemia. A literature review was conducted using the search terms "hyperammonemia", "urea-cycle disorder", "aplastic anemia". A genetic analysis of the patient included the Blueprint Genetics Comprehensive Hearing Loss and Deafness Panel Plus Hyperammonemia and Urea Cycle Disorder Panel. Results: A 17-year-old female status post-treatment with immunosuppressive therapy (IST) for severe aplastic anemia (SAA) presented with decreased level of consciousness and was found to have severe hyperammonemia with an ammonia level of 620 umol/L. Her SAA subsequently relapsed and she underwent haploidentical bone marrow transplant, which she tolerated well without complications related to hyperammonemia. Whole-exome DNA sequencing was completed and revealed no identifiable genetic cause for her hyperammonemia. An episode of acute typhlitis and subsequent appendiceal perforation and intra-abdominal sepsis may have contributed to the hyperammonemia. Conclusion: A novel case of aplastic anemia and hyperammonemia is presented and discussed in the context of the most recent reviewed literature. Nunes, Roosevelt Santos develop acute respiratory failure and requiring intubation. Hypoxia and invasive mechanical ventilation alter cerebral blood flow, increase intracranial pressure and induce an inflammatory response in the brain. These secondary brain injuries imply cerebrovascular hemodynamics disorders and intracranial compliance. Objective: The present study aims to assess the presence of the impairment of cerebrovascular hemodynamics and intracranial compliance in patients with severe COVID-19 on mechanical ventilation. Method: This study was conducted among patients with hypoxemic respiratory failure due COVID-19 without signs of cerebral evolviment prior intubation. We performed transcranial Doppler sonography and ocular ultrasound during first 24h of mechanical ventilation. Cerebrovascular hemodynamics was assessed using mean flow velocities in the middle cerebral arteries (MCA), resistance index (IR), autoregulation (transient hyperemic response test) and estimated cerebral perfusion pressure (eCPP) while intracranial compliance was evaluated by using the measurement of optic nerve sheath diameter (ONSD). Results: Fourteen patients (9 male; mean age, 60,4 years; 8 died) were assessed. The average mean blood flow velocity in MCA was of 47,1 cm/s. One patient had hyperemia. eCPP below 60 mmHg was present in 13 patiens. The mean IR was of 0,62 and the mean IP was of 1,10 indicating increase of cerebral vascular resistance. Six patients (58,3%) had an abnormal transient hyperemic response test. Five patients (35,7%) showed ONSD values higher than 5 mm indicating decrease of intracranial compliance. Conclusions: This study showed increased of indexes of cerebral vascular resistance, decreased cerebral perfusion, impaired autoregulation and decreased intracranial compliance in patients with COVID-19 during first 24 hours of mechanical ventilation. Introduction/Background: Nova Scotia has relatively high rates of organ donation, but internationally, Canada's and Nova Scotia's organ donation rates are lower than many other national averages. Deemed consent is seen as a tool to help increase donation rates but can generate controversy. In 2019, Nova Scotia became the first jurisdiction in North America to pass deemed consent organ donation legislation. The announcement of the legislative change generated substantial online discussion. Objective: We analyzed the online commentary to gain insights into public perception and online discussion characteristics, which could be used to inform public outreach both in Nova Scotia and prospective jurisdictions. Methods: We performed directed content analysis on 2663 user-generated comments appearing on two widely-shared Canadian Broadcasting Company (CBC) articles published online in April 2019. We determined levels of support and opposition in comments and described the specific rhetoric used for doing so. We also performed one-way ANOVA and Pearson chi-square tests to determine how the comments were being received and engaged by other users. Results: There were more negative than positive comments, and negative commentary generated more replies. Positive comments were received more positively by other users, while negative comments were received more negatively. The total sum of negative comments was greatly influenced by a small number of very active participants. Those in favour saw the changes as a means of addressing organ shortages while maintaining choice. Positive comments portrayed the law as altruistic and a point of pride for the province. Those in opposition saw the law as an overreach of government authority, thereby unjustly impinging on the freedoms and autonomy of individuals. Posts expressed sentiments of condemnation on various grounds, including legal issues, ethical impropriety, and insufficient consultation. Some heated arguments took place among participants. Conclusions: There were strong positive and negative sentiments expressed in the comments, but the total sum of negativity in the comments was significantly influenced by a small number of commentators. While not generalizable to the public, the findings suggest that a relatively small group of very loud voices might have created a false impression of broad social contention on the topic. Much of the expressed issues with deemed consent were broad, principle-based and tinged with conspiratorial sentiments, showing a general mistrust in health care systems. Suggestions for public outreach include clear explanations around the need for this legislative change, how the policy will be enacted (e.g. power of families to veto), and what is hoped can be gained from the policy. Effective communication and outreach should include participation from a range of stakeholders such as medical experts, religious leaders, as well as influential members of racialized and/or marginalized communities. Explanations of the organ donation and transplantation process as well as the legal foundation of the legislation might also prove to be useful for consensus building in some contexts. Public health officials should consider going online to participate idiscussions, using best online practices for transmitting facts, countering misinformation, clarifying procedures, and building public confidence/trust. Introduction: Critically ill intensive care unit (ICU) patients receiving mechanical ventilation are at increased risk of nosocomial infection with ventilator-associated pneumonia (VAP). While Candida spp. are commonly detected in the lower respiratory tract (LRT), they are generally considered colonizers rather than a pathogenic cause of infection and empiric antifungal treatment is not recommended unless the patient is experiencing shock, multi-organ failure, and more than one site isolate 1, 2 . It is estimated that Candida spp. colonization of the respiratory tract may be present in over half of critically ill patients undergoing mechanical ventilation 3 . In a Canadian study of ICU patients with suspected VAP and Candida spp. found in a LRT sample, in-hospital mortality was 34.2% and 29.8% of patients received antifungal treatment during the course of the study 4 . A recent European study found an in-hospital mortality rate of 40% and 32% of patients receiving antifungal therapy 5 . Objectives: This study aims to evaluate the use of antifungals in the treatment of ICU patients with LRT isolates positive for Candida spp. and their clinical outcomes. Methods: A retrospective analysis of 200 patients admitted to ICUs in Regina, SK that had positive Candida spp. identified on LRT isolates was performed. Results: Patients had a median age of 64 years (interquartile range [IQR] 55-74) and 50% were female. On admission, the mean SOFA score was 10 (Standard deviation [SD] ± 3) and the median duration of intubation was 21.50 days (IRQ 5-37). ICU and hospital length of stay were a median of 12 days (IQR 4-14) and 24 days (IQR 8-29), respectively. One hundred and sixty (80%) patients died in hospital. Nearly 94% of patients received antibiotic therapy prior to a positive fungal LRT isolate. Only 51.5% of patients received an antifungal treatment. Patients were more likely to be given antifungal therapy if they had experienced shock or received parenteral nutrition. Univariable logistic regression of antifungal treatment was associated with an odds ratio (OR) of 0.44 (95% confidence interval [CI] 0.21-0.90) of death, compared to no treatment (p=0.03). Multivariable logistic regression, after adjusting for age, sex, Charlson Comorbidity Index (CCI), and SOFA score, showed antifungal treatment was associated with an OR of 0.39 (95% CI 0.17-0.87) of death, compared to no treatment (p=0.02). In a sensitivity analysis, fluconazole treatment and micafungin/caspofungin treatment was associated with OR 0.31 (95% CI 0.13-0.77, p=0.01) and OR 0.59 (95% CI 0.21-1.70, p=0.33) when compared to no treatment, respectively. Propensity score match (PSM) logistic regression demonstrates antifungal treatment is associated with OR 0.41 (95% CI 0.17-1.01) of death, compared to no treatment (p=0.05). Conclusion: There is high mortality among patients with positive Candida spp. LRT cultures regardless of treatment. Although existing literature suggests antifungal treatment of Candida spp. LRT colonization may not confer benefit in terms of outcomes, there are a lack of high-quality studies evaluating antifungal therapy in these cases. Our results indicate a potential that antifungal therapy reduces the risk of mortality in these critically ill ICU patients and should prompt further investigation in larger studies. Our review of local practice is also hypothesis generating with the overall in-hospital mortality rate much greater than other trials reported in the literature. Background: Physical restraints are associated with adverse physical, emotional and psychological sequelae and do not prevent accidental device removal in intensive care unit (ICU) patients. For these reasons, legislation mandates, and professional society guidelines strongly recommend physical restraint minimization interventions. Nevertheless, physical restraints continue to be used extensively in ICUs both in Canada and internationally. Previously, implementation science frameworks have not been used to develop and guide the implementation of restraint minimization interventions. Objective: To evaluate current physical restraint practice using the integrated-Promoting Action on Research Implementation in Health Services (i-PARIHS) framework as a preliminary step to designing a theoretically-informed restraint minimization intervention. Methods: We conducted a prospective observational study of daytime restraint practices in a single,20 beds, tertiary academic ICU in Toronto, Canada. Data collection methods included hourly patient observation, medical record review, and bedside nurse informal interviews. Results: During the 12-week study period, 102 physically restrained patients were observed. The mean patient age was 58 years (SD 1.92); 67 (66%) were male. Trauma was the most frequent reason for admission (n = 43, 42%). The median ICU length of stay was 4.6 days (IQR 4.7-9.8). The precise time of physical restraint application was ascertained for 83 (81%) patients. Almost all patients (80/83, 96.4%) were mechanically ventilated. On admission, 83 (100%) had pro re nata orders for physical restraint application, and 59 (71%) were prophylactically restrained. Sedation agitation scores at time of physical restraint application were documented for 77 patients. Of these 77 patients, 55 (71%) were heavily sedated or in a comatose state. Of the 923 hourly observed physical restraint episodes, 691 (75%) were not documented in the patient record. Of the 30 daytime interprofessional team rounds observed, physical restraint was discussed at 3 (10%). Final restraint removal was ascertained in 57 of 102 patients. In 23 (40%) of these patients, physical restraint removal was documented in the patient records. Over half of restraints (30/57, 52.6%) were removed after extubation. Of the eight patient-initiated self-extubation episodes, all were physically restrained at the time of self-extubation. Conclusion: Our data indicate common practices of prophylactic physical restraint upon ICU admission, omission of clinical documentation, and limited interprofessional discussion on rounds, all of which may contribute to high restraint use. Further exploratory research is needed to qualitatively understand current physical restraint practice and potentially modifiable i-PARIHS domains (innovation, recipients, context, facilitation) to inform the design, implementation and evaluation of a restraint minimization intervention. This study was funded through graduate awards provided by Lawrence S. Bloomberg Faculty of Nursing, University of Toronto Isaac , Chartelin Jean Objectives: Patients 65 years of age or older now represent more than 60% of injury hospitalizations in Canada. Geriatric patients with orthopedic injury often have long hospital stays with a high incidence of complications (nosocomial infections, delirium), functional decline, discharge to long-term care, and increased mortality. There is a knowledge gap on the characteristics of patients who could most benefit from an interdisciplinary treatment approach to improve outcomes and reduce resource overuse. We aimed to identify variables that are associated with adverse outcomes and high resource use in elders admitted to a trauma center for an isolated orthopedic injury. Methodology: We conducted a multicenter retrospective cohort study on elders hospitalized with a primary diagnosis of isolated orthopedic injury (n=19928). Data were extracted from the provincial trauma registry (Registre des traumatismes du Québec-RTQ). ). We identified potential predictors by consulting the literature and clinical experts (e.g., age, sex, comorbidities, mechanism of injury, hospitalizations in the year prior to the injury, concomitant mild traumatic brain injury). Outcomes were mortality, complications, discharge to long-term care, and extended length of stay. We used a multi-level logistic regression to estimate the association between predictors and adverse outcomes. Results: Overall, 18.6% (n=3684) had an extended length of stay, 19.5% of patients had complications, 5.5% died in hospital, 10.8% were transferred to a long-term care facility, and 8.6% had unplanned readmission. Increasing age, male sex, certain comorbidities (malignancy under chemotherapy, dementia, cirrhosis, diabetes with chronic renal failure, heart failure, loss of independence), selected orthopedic injuries (lower limb fracture, hip fracture, pelvic ring fracture), severe orthopedic injuries (Abbreviated Injury Score-AIS 3), concomitant head injury, and admissions in the year before the injury was associated with an increased odds of an adverse outcome. In addition, patients admitted for surgical care had a lower odds of mortality, unplanned readmission, and adverse discharge destination. Conclusion: We identified eight predictors of adverse outcomes in patients 65 years of age admitted to a trauma center for orthopedic injury. In later phases, these factors will be used to develop a clinical decision rule to identify elders who may benefit the most from interdisciplinary care. Objectives: This study reports three cases of globe-threatening neurotrophic ulcerative keratitis arising in the ICU setting following neurosurgical procedures. The current state of ocular care across ICUs in Ontario was investigated and an algorithmic ocular care protocol for ICU patients is discussed. Methods: This study included a retrospective chart review of patients developing exposure keratitis in the ICU setting. A telephone survey of intensive care units in major cities in Ontario was conducted. ICU charge nurses were asked about ocular care in their respective units. Questions focused on eye care protocols, assessment of eyelid closure, methods of ocular surface protection, recent complications, and ophthalmology consult practices. Data were reported in aggregate. Results: We present the clinical course and outcomes of two female and one male patient with a mean age of 47 who developed significant exposure keratitis and corneal ulcers in the ICU following neurosurgical procedures. Despite numerous interventions, their visual outcomes remained poor: Patient 1's visual acuity was counting fingers at the face, Patient 2 underwent enucleation due to poor vision (hand motions at the face) and pain, and Patient 3's visual acuity was 20/400. Eighteen ICUs provided responses to the questionnaire. Eyelid closure was formally assessed in 56% (10) of units. Less than one third (5; 28%) of ICUs reported having an eye care protocol that is routinely implemented for unconscious patients, while 72% (13) reported a protocol for patients who are unable to close their eyes. Ointment (17; 94%) and artificial tears (16; 89%) were common components of protocols, with 15 intensive care units (83%) using both. The majority of these protocols indicated tears or ointment on an as-needed basis, with one ICU reporting tears prn as the only component of their protocol. Infection and redness/irritation were the most common reasons an ophthalmology consult would be made. Additionally, five (28%) units indicated that a consult would be made for any eye problem encountered. Corneal abrasion, ulceration, unilateral blindness, infection, stretched optic nerve, and swollen orbit were reported as complications recently encountered. Conclusions: Prevention of exposure keratitis is inconsistent between individual ICUs, with some operating in the absence of defined protocols for ocular protection. Variability and inconsistencies within ocular care practices may be causing undue harm to patients at risk. These findings highlight the importance of implementing a simple ocular care protocol across ICUs. We propose universal precautions be initiated on admission to ICU for all unconscious patients and patients who cannot blink or close their eyes. This would require instillation of non-preserved ointment every 4 hours. Prior to instillation of ointment, an ocular surface assessment should be conducted every 4 hours for purulent discharge, conjunctival hyperemia, and opacification of any kind on the cornea. If any of these are identified, an ophthalmology assessment should be requested. CCRT consults grew substantially resulting in the need to identify and prioritize patients for the Intensive Care Unit (ICU), inter-regional IMS transfers, and acute COVID-19/Optiflow cohorting throughout the organization. By automatically retrieving patient information from the electronic medical record (EMR), the CCRT Shift Utilization Report was digitized to create patient lists shared with patient flow and CCRT members. Providing a consistent list for improved accessibility, documentation accuracy and automaticity to support acute patient management and response to patient care by reducing CCRT workload. Objective: To standardize and increase efficiency reporting patient information using the CCRT Shift Utilization Report. Method(s): Multiple stakeholders collaborated to develop and evaluate opportunities to improve nursing workflow through digitizing the CCRT Shift Utilization Report. End-user engagement from CCRT nurses and physicians was prioritized throughout the process to ensure data accuracy and practical implementation. The CCRT Shift Utilization Report was launched in February 2021. Result(s): Implementing the CCRT Shift Utilization Report as a resource planning strategy was timely and enabled the efficient management of increased patient volumes during the COVID-19 pandemic. End-user feedback revealed the automated report was significantly easier to use, reduced redundancy in documentation, and improved accessibility and transparency. Conclusions: The impact of an automated CCRT utilization report is an intervention designed to alleviate time spent on reporting utilization via shift log report. This intervention will notably reduce CCRT nurse workload and support resource planning strategies in response to recent increases in CCRT demand. Introduction: There are limited available data on factors associated with extubation failure in patients with acute brain injuries (ABI) 1 ; the strength and direction of association of patient factors with extubation outcome in published studies are variable. Objectives: To systematically review prognostic factors associated with extubation failure in adult patients with ABI, focusing on Glasgow Coma Score (GCS), cough, secretion burden, and hemodynamic and airway factors. Methods: MEDLINE, Embase, and Cochrane Central were searched from inception through February 2021. Two reviewers independently selected English-language studies reporting prognostic factors and their association with extubation failure in adult patients (age 18) with ABI receiving mechanical ventilation for >24 hours. The primary outcome was extubation failure, defined as the need for reintubation within 72 hours of a planned extubation attempt. Meta-analysis was performed using a random effects model across five broad domains of factors: demographic factors (age, baseline co-morbidities), neurologic status (diagnosis on admission, GCS), mechanical ventilation factors on extubation day (rapid shallow breathing index (RSBI), positive end expiratory pressure (PEEP)), airway protection factors (cough, gag, swallow), and hemodynamic and gas exchange factors on extubation day (heart rate, blood pressure, P/F ratio). Results were reported as odds ratios (OR) for binary prognostic factors or as ratios of means (RoM) for continuous factors 2 . Study risk of bias was assessed using the Quality in Prognostic Factors (QUIPS) tool 3 . This systematic review followed established reporting standards for prognostic factor studies 4 , the Cochrane Prognosis Methods Group, and the updated Preferred Reporting Items for Systematic Review and Meta-analysis (PRISMA) guidelines 5 . The protocol was registered with PROSPERO (CRD42021253310). Results: Of 5,998 articles screened, 101 articles were reviewed in full text and 17 studies were included in the final review. Extubation failure was less likely in the presence of a strong cough (OR 0.54; 95% CI 0.32-0.89) and swallow (OR 0.29; 95% CI 0.15-0.58), and more likely in the presence of heavy secretion burden (OR 1.78; 95% CI 1.05-3.02). Among continuous variables, extubation failure was more common with older age (RoM 1.08; 95% CI 1.03-1.13) and higher APACHE II score (RoM 1.12; 95% CI 1.05-1.18). A higher GCS on extubation day was associated with reduced extubation failure (RoM 0.91; 95%CI 0.88-0.94). There was no association between sex, baseline co-morbidities, or neurologic diagnosis (traumatic brain injury, subarachnoid hemorrhage, intracranial hemorrhage, or ischemic stroke). RSBI, PEEP, and all hemodynamic and gas exchange factors were not associated with extubation failure. Risk of bias according to QUIPS varied from low to moderate across the majority of domains. Conclusion: In this systematic review and meta-analysis of adult patients with ABI, factors associated with increased risk of extubation failure included older age, higher APACHE score, low GCS on extubation day, and heavy secretion burden. Presence of a strong cough and swallow were associated with reduced risk of failure. Future work could aim to integrate these factors into a clinical prediction model. Any psychiatric disorder denotes anxiety, depressive, trauma-and stressor-related, substance use, and psychotic disorders. Propensity scores were based on patient age, sex, admission type (no surgery, elective surgery, emergency surgery), admission Charlson index score, admission APACHE-II and APACHE-III score, use of invasive mechanical ventilation (yes/no), use of non-invasive mechanical ventilation (yes/no), use of vasoactive medications (yes/no), use of continuous renal replacement therapy (yes/no), ICU length of stay (days), hospital type (tertiary, community, regional), and teaching hospital status (yes/no). Propensity scores were used in inverse probability weighted logistic regression models (that reweights patients based on the propensity score to make them more representative of the population. Introduction: Healthcare teams are made up of both leaders and followers. Followers make up the majority of the healthcare team and greatly influence the quality of care each patient receives. There are five followership styles which have been described by Kelly based on critical thinking and active engagement. Followership type may prove to be correlated with burnout syndrome, which occurs when an imbalance is created between personal characteristics of the health care worker and the work-related issues and organizational factors. Objective: We aim to explore if a relationship exists between followership style and burnout as well as followership style and job satisfaction of followers within the critical care setting. Additionally, we aim to quantify the distribution of followership types amongst followers within the critical care setting. Methods: A total of 64 participants (27 residents and 37 critical care nurses) participated in a single centered, cross sectional survey. A four-part survey was completed by each participant to classify the participant's followership type (Kelly followership type), burnout (Maslach Burnout Inventory) and job satisfaction (Brayfiled-Rothe Survey and Work and Meaning Inventory). Correlations between followership type and burnout as well as followership type and job satisfaction were then determined. Results: There was a weak to moderate correlation between independent critical thinking and personal accomplishment (R=0.297), and moderate correlation to meaningful work (R=0.390), and job satisfaction (R=-0.300). Active engagement was moderately correlated with personal accomplishment (R=0.302), meaningful work (R=0.448) and job satisfaction (R=-0.418). Neither independent critical thinking nor active engagement showed significant correlation with depersonalization and emotional exhaustion subscales (Tables 1,2 ). The majority of both residents and nurses were characterized into effective/exemplary followership type with no statistically significant differences between these groups (Tables 1,3) . Conclusion: Understanding the followership type of healthcare providers is an important first step in fostering enhanced team dynamics. This research shows that by creating an environment which promotes critical thinking and active engagement, nurses and residents may display less burnout, and enhanced job satisfaction. Methods: This study was conducted among patients with hypoxemic respiratory failure due COVID-19 without kidney disease prior ICU admission in a Brazilian intensive care unit. We assessed renal perfusion by using resistive index and color-Doppler semiquantitative evaluation during first 24h of mechanical ventilation. Renal resistive index is normally lower than 0.70. Semiquantitative color-Doppler scale for evaluating intrarenal perfusion: 0, absence of renal perfusion; 1, few vessels visible in the vicinity of the hilum; 2, hilar and interlobar vessels visible in most of the renal parenchyma; 3, renal vessels identifiable until the arcuate arteries in the entire field of view. Results: Fifteen patients (10 male; mean age, 62,2 years; 8 were died) with severe COVID-19 were assessed during first 24h of mechanical ventilation which mean PaO2 / FiO2 ratio was 183,3. All patients received tidal volume < 6 mL/kg predicted body weight and mean driving pressure was 11,06. Five patients had AKI stage 1 and no one had AKI stage 2 or 3. Seven patients had renal resistive index higher than 0.7 and eight patients had grade 1 of semiquantitative color-Doppler scale. Conclusions: This study showed impairment of renal perfusion in critically ill patients with COVID-19 during first 24h of mechanical ventilation. Introduction/Background: Randomized Controlled trials (RCTs) are the gold standard when it comes to examining the efficacy and safety of ICU interventions. The underrepresentation of certain populations within RCTs limits the generalizability of findings. In Canada and the US, Black people disproportionately require intensive care and rates of stroke and sepsis are higher in Black populations than in non-Black populations. Thus, it is crucial to ensure adequate representation of Black participants in critical care RCTs. Objectives: The objective of this systematic review is to investigate the proportionate representation of Black people enrolled at Canadian and US study sites from major critical care RCTs published in the last 5 years. Methods: We performed a search of critical care RCTs published in 3 major general medicine journals (JAMA, NEJM, Lancet ) and 4 ICU journals (Critical Care Medicine, Intensive Care Medicine, American Journal of Respiratory and CHEST) between January 1, 2016 and December 31, 2020. We included RCTs that enrolled critically ill adults (>16 years) at US or Canadian sites, and provided a breakdown of racial demographic data by study site. For studies with multiple international sites, we only included the Canadian and US sites in the analysis. We contacted study authors of potentially eligible studies if the necessary race-based was unavailable. Two reviewers screened all citations in two stages and extracted data independently and in duplicate. We describe results narratively and compare study-based demographics to publicly available city-based demographics (using US Census and StatsCan). We pooled representation of Black people across studies, cities and centers using a random effect model and used meta-regression to explore the impact of certain variables (country, drug intervention, consent model, multicentre vs single centre, industry funding and year of publication) on Black representation. Results: Of 737 citations, we included 21 RCTs that examined a number of different ICU interventions. Of the included studies, 9.5% (2/21) consisted of solely Canadian sites, 81.0% (17/21) consisted of solely American sites, and 9.5% consisted of both; 42.9% (9/21) of the studies were single centre while 57.1% (12/21) of the studies were multicentre trials. Pooled across all studies, Black people were underrepresented in critical care RCTs by 6% compared to population-based city demographics (95% confidence interval [CI]: 1 to 11%) and underrepresented in 17 of the 21 included studies. Meta-regression showed that US-based sites underrepresented Black people more than Canadian sites (6% in US studies, 4% in Canadian studies, subgroup effect p=0.02). There were no other subgroup effects demonstrated. Conclusion: The findings of this systematic review suggest that Black people are underrepresented in critical care RCTs compared to city-based demographics. The lack of adequate representation in these RCTs may be a crucial factor contributing to the disproportionate adverse health outcomes among Black people. Ultimately, the results of this study illustrate the need for action from both Canadian and American researchers to ensure more equal representation to maximize the quality and generalizability of healthcare delivery. Further research is needed to investigate the full extent of Black underrepresentation in critical care trials and to identify other contributing factors. not associated with cumulative fluid balance (over 4 days), APACHEII, age or sex. Conclusions: Na increase, including to 145 mEq/L, is common during recovery of AKI. Fluid and sodium intake seem to have no impact on Na during this phase. Although we did not directly measure free wáter administration, the lack of association between fluid intake and Na suggests that free water may have no effect on Na during AKI recovery. Introduction: While the Intensive Care Unit (ICU) often experiences staffing challenges, the COVID-19 pandemic exacerbated the situation when occupancy rates skyrocketed to 95%. A workforce planning strategy focused on deploying alternative care providers (ACPs) was implemented to optimize staffing ratios and meet capacity demands. ACPs consisted of redeployed medicine nurses or student learners, who were provided educational support and supervision to ensure safe patient care and role clarity. In parallel, participant engagement centered around maximizing the learning potential of the ACPs to build competency, while ICU staff served as preceptors to support the integration of ACPs into the ICU. Objective: To engage alternate care providers through educational opportunities to support the ICU workforce Methods: Collaborated with Professional Practice to ensure role clarity for ACPs by considering their unique knowledge, skill, and competency levels Provided individualized learning packages to ACPs and ICU preceptors to facilitate learning and transition into the ICU team Surveyed ACPs on the effectiveness of this integrative workforce strategy Results: By focusing on education and engagement in the ICU workforce, the burden exerted on the ICU was reduced. Survey results revealed that 82.75% of ACPs reported positive experiences, with an additional 75.86% of ACPs indicating an interest in pursuing a career in Critical Care Nursing. Background and Objective: Different aerosol barrier enclosure systems to protect healthcare workers from airborne contaminants have been recently designed but their efficacy and safety have been questioned. The CanoPPE is a novel system with improved ergonomics and a negative pressure suctioning system to minimize dispersion risks. We tested the efficacy of retaining aerosolized particles and the safety of this device in bench, healthy volunteer, and initial clinical studies. Methods: A manikin with an airway connected to a breathing simulator was placed inside the CanoPPE. Negative pressure inside the device was applied using vacuum wall suction. With this configuration, we simulated active breathing, cough, fluorescent microparticle aerosolization (Glo Germ Oil -0.1 to 20 m), and carbon dioxide (CO 2 ) production (6L/min, 5% CO 2 ). High-flow nasal cannula (HFNC) therapy was applied inside the CanoPPE at flow rates of 30 and 60L/min. Furthermore, CanoPPE was assessed for leakage in an airtight aerosol chamber. Latex aerosol microparticles (0.12 m) were introduced into CanoPPE while HFNC at 60L/min and a suction of 80L/min was applied; particle counts were measured at regular intervals from air sampled inside and around the CanoPPE. CanoPPE was also tested on healthy volunteers breathing spontaneously. Last, we tested the feasibility of five intubation procedures in elective surgical cases. Results: The design of the CanoPPE was originally adjusted until no fluorescent particles were visualized in the surrounding area illuminated by ultraviolet light. The efficacy of the device in retaining microparticles was confirmed quantitatively in a controlled environment by the absence of leakage from the CanoPPE. CO 2 accumulation inside the CanoPPE showed an inverse correlation with the suction flow rate in all conditions tested (normal breathing and HFNC 30 or 60L/min) in both the bench and the healthy volunteer studies. Particle removal efficacy and safety environmental conditions in terms of CO 2 , temperature and humidity were achieved when the suction flow rate was set at a minimum of 60L/min or at least 20L/min above the HFNC set flow. Five patients were successfully intubated in the operating room without ergonomic difficulty. Conclusion: Unlike other enclosure barrier devices, the efficacy and safety of the CanoPPE were confirmed by several tests from prototyping to initial clinical application. Our results support its reliability for clinical use and demonstrate its dependency on the negative pressure system. The suction flow rate must be set at a minimum of 60L/min or 20L/min higher than the HFNC flow rate to ensure healthcare workers and patient safety. Our promising results suggest that the CanoPPE is an additional barrier against airborne transmission. 137 Introduction: Sepsis remains a leading cause of worldwide morbidity and mortality in children. Corticosteroids are a controversial treatment of septic shock with unclear efficacy in children and sigificant side effects. Mortality risk stratification may identify a subset of patients who benefit from or be harmed by corticosteroid administration. We have previously developed and validated the PERSEVERE-II score, a biomarker-based mortality risk stratification tool for pediatric sepsis. To determine the effect of corticosteroid administration on 28-day mortality within level of baseline mortality risk score (PERSEVERE II) in a cohort of children with septic shock. Methods: We performed a secondary analysis using prospectively collected data (December 2014-March 2019) of an observational cohort of children with septic shock from 13 centres in the United States of America. All healthcare providers and caregivers were blinded to PERSEVERE-II scores. Our analysis included logistic regression (outcomes 28-day mortality, complicated course), inverse-probability treatment weighting (outcome 28-day mortality), survival analysis (outcome ICU-free days) and linear regression (outcome maximum failed organs). We defined complicated course as a death by 28 days or at least two failing organs on day 7 of septic shock. Results: A total of 461 patients were included in analysis (215 corticosteroids exposure, 246 no corticosteroid exposure) with an average age of 7.1 years (IQR 2.2, 13.6). In the subgroup of patients with a high PERSEVERE II score, corticosteroid administration was associated with an increased adjusted risk of 28-day mortality (OR 4.28 (1.77-10.33), p=0.001), but not in the low risk group (OR 0.14 (0.01-1.37), p = 0.09). A significant interaction between PERSEVERE II score and corticosteroids was seen for both secondary outcomes complicated course (p=0.01) and maximum failed organs (p<0.001). Corticosteroid exposure was associated with less ICU-free days (p<0.0001). In our multicentre observational study, corticosteroid administration was associated with increased mortality in a subgroup of children with a high PERSEVERE-II score. 1. Evaluate the diagnostic accuracy of PC for adult sepsis a. Evaluate the diagnostic accuracy of PC for sepsis-induced disseminated intravascular coagulation (DIC) 2. Assess the prognostic strength of PC for sepsis-related mortality Methods: We searched, from inception to January 12 th , 2020, Ovid MEDLINE, EMBASE, PubMed, Cochrane Library and CINAHL. Two reviewers, independently and in duplicate, screened articles to identify eligible studies. Our patient population consisted of adults with sepsis as defined by the sepsis international consensus definitions, or suspicion of sepsis. Prospective observational studies measuring PC levels within 24 hours of sepsis presentation were included. Independently and in duplicate, we performed data abstraction, risk of bias (RoB) assessment using the QUADAS-2 and QUIPS tools, and certainty assessment using GRADE. We performed meta-analyses using fixed or random effects models depending on between-study heterogeneity. Sensitivity analysis was conducted for our prognostic outcome by removing high RoB studies, and sub-group analysis was used to evaluate 28-day sepsis-related mortality. Results: We identified 12 studies that met the inclusion criteria for the systematic review, and 8 were synthesized for meta-analysis (see references and Figure 1 & 2) . Three studies examined the diagnostic outcome, 3 examined the prognostic outcome, and 6 examined both outcomes. Data could not be synthesized on our primary diagnostic outcome due to the heterogeneity of the control groups in each study. Pooled analysis (Figure 1 ) demonstrates moderate certainty evidence of difference in PC levels between sepsis survivors and non-survivors (SMD 0.53, 95% CI 0.25-0.81, p=0.0002, I 2 =55%). Heterogeneity was reduced in our subgroup (SMD 0.44, 95% CI 0.26-0.61, p<.00001, I 2 = 0%) and sensitivity (SMD 0.44 95% CI 0.25-0.62, p<0.0001, I 2 =0%) analyses. Pooled analysis (Figure 2 ) also demonstrated low certainty evidence of difference in PC levels between septic patients with and without DIC (SMD 0.83, 95% CI 0.66-1.00, p<0.00001, I 2 =20%). Our findings are limited by high RoB in studies due to missing information on patient selection, insufficient data reporting, and unexplained missing patient biomarker samples. Conclusions: We demonstrate that PC can be used as a tool to distinguish patients with worsening severity of sepsis and those at risk for mortality. However, we were unable to assess PC as an early diagnostic tool due to limited available literature. We Introduction: Sepsis and septic shock are a leading cause of mortality, morbidity and increased healthcare expenditure in Canada and worldwide 1, 2 . Capturing sepsis patients using ICD-10 codes from health administrative data is challenging because it is highly undercoded 3 . Although ICD codes were specific (median: 98.5%, range: 78.3% to 100%), these codes were not sensitive (median: 42.4%, range: 5.9% to 82.3%) 4 . The addition of antimicrobial data has been proposed to further improve the performance of ICD-10 sepsis identification algorithms 3, 5 . However, this strategy has not been applied in sepsis validation studies. Objectives: To determine whether antimicrobial data improves the diagnostic accuracy of the existing Canadian sepsis identification algorithms. Methods: We are conducting a review of medical charts of 850 adult patients admitted to The Ottawa Hospital General and Civic campus ICUs between April 2014 and March 2019. Patients are classified as infected or non-infected based on a modified Sepsis-3 criteria. Chart review data will be linked with health administrative data (for ICD-10 codes and antimicrobial data) housed at the Ottawa Hospital Data Warehouse. Our primary outcomes include the performance characteristics (Sensitivity(Sn), Specificity(Sp), Positive Predictive Value(PPV), Negative Predictive Value(NPV)) of the modified algorithm including antimicrobial data, with corresponding 95% CI when compared to the existing Canadian algorithms 3, 7 . Preliminary Results: We have reviewed a total of 475 charts (55.8%) of which 458 were included. Of the included charts, 210 (45.9%) were classified as infected and 248 (54.1%) as non-infected. The median patient age was 65 (52,74) years. Of the 458 included patients, the majority was male (62.0%). 30% (N=63) and 18.1% (N=45) of infected and non-infected patients died during their admission. Diabetes (24.6-44.8%) and cancer (18.1-31.4%) were major co-morbidities of patients in both infected and non-infected cohorts. Among the infected group, most infections were respiratory in origin (46.4%) and most patients had at least 2 antimicrobials initiated within 24 hours of documented infection (29.5%). Both cohorts had varying degrees of organ dysfunction, which was overall more pronounced in the infected group, particularly that of respiratory and renal dysfunction (37.1% and 32.9%, respectively). Conclusion: Our preliminary results reveal that it is feasible to apply a modified Sepsis-3 criteria to identify patients with sepsis from medical charts. Our presentation will report the impact of adding various types of antimicrobial data on the diagnostic accuracy of algorithms used to identify sepsis cases from routinely collected data. Diagnosis and Management of Spinal Muscular Atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care Diagnosis and Management of Spinal Muscular Atrophy: Part 2: Pulmonary and acute care, medications, supplements and immunizations, other organ systems, and ethics Nutritional status and nutrient intake challenges in children with spinal muscular atrophy Describing nutrition in spinal muscular atrophy: A systematic review Low bone mineral density and fractures are highly prevalent in pediatric patients with spinal muscular atrophy regardless of disease severity Spinal Muscular Atrophy type 1 and 2: what are the differences in body composition and resting energy expenditure? Predictive energy equations for SMA type 1 Special Considerations in the Respiratory Management of Spinal Muscular Atrophy Trajectory of change in the swallowing status muscular atrophy type 1 Recommendations for the diagnosis and management of typical childhood spinal muscular atrophy Childhood spinal muscular atrophy: Controversies and challenges Grant Acknowledgement: I would like to thank the wonderful team Do outcomes vary according to the source of admission to the pediatric intensive care unit? Pediatric Critical Care Medicine Description of PICU Unplanned Readmission. Pediatric critical care medicine Executive Summary: STEP expansion to include admitted patients within the Emergency Department at Alberta Children's Hospital. Unpublished raw data Ontario Pediatric Critical Care Response Team Collaborative. Implementation of a multicenter rapid response system in pediatric academic hospitals is effective Determination of Brain Death/Death by Neurologic Criteria: The World Brain Death Project Determination of death by neurologic criteria around the world Flow is not perfusion, and perfusion is not function: Ancillary testing in brain death Ancillary testing for diagnosis of brain death: a protocol for a systematic review and metaanalysis Management of Acute Respiratory Distress Syndrome and Refractory Hypoxemia. A Multicenter Observational Study Error-checking intraoperative arterial line blood pressures Extracorporeal Cardiopulmonary Resuscitation in Adults. Interim Guideline Consensus Statement From the Extracorporeal Life Support Organization American Heart Association Focused Update on Advanced Cardiovascular Life Support: Use of Advanced Airways, Vasopressors, and Extracorporeal Cardiopulmonary Resuscitation During Cardiac Arrest: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation Improved Survival With Extracorporeal Cardiopulmonary Resuscitation Despite Progressive Metabolic Derangement Associated With Prolonged Resuscitation. Circulation Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an observational study and propensity analysis Extracorporeal resuscitation for refractory out-of-hospital cardiac arrest in adults: A systematic review of international practices and outcomes Influence of low-flow time on survival after extracorporeal cardiopulmonary resuscitation (eCPR) Review of abdominal damage control and open abdomens: focus ongastrointestinal complications Bedside dressing changes for open abdomen in the intensive care unit is safe and time and staff efficient. Crit Care Cardiopulmonary resuscitation is not addressed in the admitting medical records for the majority of patients who undergo CPR in the hospital Frequency and clinical relevance of inconsistent code status documentation Processes of code status transitions in hospitalized patients with advanced cancer Development and validation of a Hospital Frailty Risk Score focusing on older people in acute care settings using electronic hospital records: an observational study Benzodiazepines and Development of Delirium in Critically Ill Children: Estimating the Causal Effect Delirium and Benzodiazepines Associated With Prolonged ICU Stay in Critically Ill Infants and Young Children Delirium in children and adolescents: A systematic review of the literature Delirium in Children: Identification, Prevention, and Management Delirium in Critically Ill Children: An International Point Prevalence Study Update for the Rogers' Textbook of Pediatric Intensive Care The effectiveness of non-pharmacological interventions in reducing the incidence and duration of delirium in critically ill patients: a systematic review and meta-analysis Beyond the drugs: nonpharmacologic strategies to optimize procedural care in children Nonpharmacological interventions for sleep promotion in hospitalized children. Cochrane Database of Systematic Reviews Comfortholding in critically ill children: a scoping review Review: Kangaroo mother care to reduce morbidity and mortality in low birthweight infants Kangaroo mother care and infant biopsychosocial outcomes in the first year: A meta-analysis Maternal-preterm skin-to-skin contact enhances child physiologic organization and cognitive control across the first 10 years of life Enjoying tactile touch and gaining hope when being cared for in intensive care--a phenomenological hermeneutical study Huggable communication medium decreases cortisol levels Interpersonal touch: physiological effects in critical care The science of interpersonal touch: an overview Social touch, CT touch and massage therapy: A narrative review Competency based medical training The CanMEDS The Scottish doctor--learning outcomes for the medical undergraduate in Scotland: a foundation for competent and reflective practitioners The ACGME outcome project: retrospective and prospective American Psychiatric Association. Diagnostic and statistical manual of mental disorders Do motor subtypes of delirium in child and adolescent have a different clinical and phenomenological profile? Association Between Pediatric Delirium and Quality of Life After Discharge A clinical study of delirium in children and adolescents Infant delirium in pediatric critical care settings Pediatric Delirium: Recognition, Management, and Outcome Delirium in Children and Adolescents Biomarkers for Pediatric Delirium Subtypes Pediatric delirium in critical illness: Phenomenology, clinical correlates and treatment response in 40 cases in the pediatric intensive care unit Detecting pediatric delirium: Development of a rapid observational assessment tool Early prediction of delirium in a pediatric cardiac intensive care unit: A pilot study Paediatric index of mortality 3: An updated model for predicting mortality in pediatric intensive care State of the science in pediatric ICU delirium: An integrative review Delirium and mortality in critically ill children: Epidemiology and outcomes of pediatric delirium Pediatric Delirium and Associated Risk Factors: A Single-Center Prospective Observational Study Pediatric delirium: epidemiology and outcomes Prolonged stay at the paediatric intensive care unit associated with paediatric delirium Implementation of an ICU Bundle: An Interprofessional Quality Improvement Project to Enhance Delirium Management and Monitor Delirium Prevalence in a Single PICU Delirium in Children after Cardiac Bypass Surgery Delirium is a Common and Early Finding in Patients in the Pediatric Cardiac Intensive Care Unit Cost Associated With Pediatric Delirium in the ICU Risk factors for the development of postoperative delirium in pediatric intensive care patients Characteristics of postintensive care syndrome in survivors of pediatric critical illness: A systematic review Patterns of Postoperative Delirium in Children Delirium and Benzodiazepines Associated with Prolonged ICU Stay in Critically Ill Infants and Young Children Delirium in children and adolescents: A systematic review of the literature Cornell assessment of pediatric delirium: A valid, rapid, observational tool for screening delirium in the PICU* Not just to survive but to thrive: Delirium in the pediatric cardiac ICU Delirium in a tertiary PICU: Risk factors and outcomes* Recognition of Delirium on Pediatric Hospital Services Delirium documentation in hospitalized pediatric patients with cancer. Palliative and Supportive Care 19 The Times They Are A-Changin": Universal Delirium Screening in Pediatric Critical Care Delirium detection based on the clinical experience of pediatric intensivists Diagnosing delirium in critically ill children: Validity and reliability of the Pediatric Confusion Assessment Method for the Intensive Care Unit The Preschool Confusion Assessment Method for the ICU: Valid and Reliable Delirium Monitoring for Critically Ill Infants and Children Development and Psychometric Evaluation of the Pediatric Anesthesia Emergence Delirium Scale On the utility of diagnostic instruments for pediatric delirium in critical illness: An evaluation of the Pediatric Anesthesia Emergence Delirium Scale, the Delirium Rating Scale 88, and the Delirium Rating Scale-Revised R-98 Validation of the SOS-PD scale for assessment of pediatric delirium: A multicenter study Delirium and Developmental Disability: Improving Specificity of a Pediatric Delirium Screen Delirium screening anchored in child development: The Cornell Assessment for Pediatric Delirium Paediatric Emergence Delirium: An Approach to Diagnosis and Management in the Postanaesthesia Care Unit Sophia Observation withdrawal Symptoms-Paediatric Delirium scale: A tool for early screening of delirium in the PICU Pediatric Delirium: a Review of Current Diagnosis and Management in the Intensive Care Setting Delírium en pediatría: detección precoz, diagnóstico y cuidado de enfermería Going home to die from surgical intensive care units The going home initiative: getting critical care patients home with hospice Criteria for Critical Care of Infants and Children: PICU Admission, Discharge, and Triage Practice Statement and Levels of Care Guidance A modified Delphi study to identify factors associated with clinical deterioration in hospitalized children Outcomes of patients considered for, but not admitted to, the intensive care unit Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries Resuscitation Fluids Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality A rational approach to perioperative fluid management Effects of intravenous fluid restriction on postoperative complications: comparison of two perioperative fluid regimens: a randomized assessor-blinded multicenter trial Effect of intraoperative fluid management on outcome after intraabdominal surgery Effect of salt and water balance on recovery of gastrointestinal function after elective colonic resection: a randomised controlled trial Fluid Management for Critically Ill Patients: A Review of the Current State of Fluid Therapy in the Intensive Care Unit Reasons for admission and mortalities following admissions in the intensive care unit of a specialized hospital Profile of Intensive Care Unit Admissions and Out-comes in a Tertiary Care Center of a Developing Country in West Africa: A 5 Year Analysis Characteristics, outcome of patients on invasive mechani-cal ventilation: A single center experience from central India Risk factors for hospital mortality among mechanically ventilated patients in respiratory ICU The outcomes and prognostic factors of patients requiring prolonged mechani-cal ventilation Mechanical Ventilation in the Intensive Care Unit: A Prospective Study of Indications and Factors that Affect Outcome in a Tertiary Hospital in Nigeria Winter 2012/2013 -Cover Story: The Global ICU Intensive Care Unit Capacity in Low-Income Countries: A Systematic Review Clinical characteristics and outcomes of patients under invasive mechanical ventilation at Ayder comprehensive specialized hospital adult intensive care unit Factors affecting pro-longed intensive care unit stay in Nigist Eleni Mohammed Memorial Hospital, Hosanna, South-ern Ethiopia Outcomes in critical care delivery at Jimma Uni-versity Specialized Hospital Predictors of Mortality in a Critical Care Unit in South Western Kenya. The ANNALS of AFRICAN SURGERY Prolonged stay in the Intensive Care Unit of a tertiary hospital in Nigeria: Predisposing factors and outcome Review of morbidity and mortality among patients admitted to the Surgical Intensive Care Unit at Tikur Anbessa Specialized Teaching Hospital Predictors of mortality in mechanically ventilated patients Intensive care medicine in rural sub-Saha-ran Africa Anaesthesia Mortality Prediction in Rural Kenya: A Cohort Study of Mechanical Ventilation in Crit-ically Ill Patients Surgical Admissions and Treatment Outcomes at a Tertiary Hospital Intensive Care Unit in Ethiopia: A Two-Year Review Patterns of Admission and Clinical Outcomes Among Patients Admitted to Medical Intensive Care Unit of a Teaching and Referral Hospital, Northwest Ethiopia. Global Advances in Health and Medicine Performance of critical care prognostic scoring sys-tems in low and middle-income countries: a systematic review Survival and Predictors of Mortality Among Patients Admitted to Intensive Care Unit in Southern Ethiopia: A Multi-center Retro-spective Cohort Study Patterns of Admission and Mortality of Patients Admitted to Surgical Inten-siv Care of Tikur Anbesssa Specialized Teaching Hospital Retrospective assessment of admission profile and outcome in intensive care unit in Jimma University Specialized Hospital Shock in an Ethiopian Medical Intensive Care Unit: Characteristics and Outcomes at Tikur Anbessa Spe-cialized Hospital Hypoalbuminemia Is a Strong Predic-tor of 30-Day All-Cause Mortality in Acutely Admitted Medical Patients: A Prospective, Obser-vational Temporal changes in incidence of dialysis-requiring AKI Exploring Potential Reasons for the Temporal Trend in Dialysis-Requiring AKI in the United States Cognitive impairment in hemodialysis patients is common Kidney function is related to cerebral small vessel disease The association between brain volumes, delirium duration, and cognitive outcomes in intensive care unit survivors: the VISIONS cohort magnetic resonance imaging study* Long-term cognitive impairment after critical illness Low brain tissue oxygenation contributes to the development of delirium in critically ill patients: A prospective observational study Dysfunctional cerebral autoregulation is associated with delirium in critically ill adults Antipsychotic prescribing patterns during and after critical illness: a prospective cohort study Antipsychotic utilization in the intensive care unit and in transitions of care Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU Delirium and exposure to psychoactive medications in critically ill adults: A multi-centre observational study Long-term cognitive impairment after critical illness Sedation, Delirium, and Cognitive Function After Critical Illness Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death Assessment of intravascular volume status and volume responsiveness in critically ill patients China coronavirus: WHO declares international emergency as death toll exceeds 200 Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China Managing mental health challenges faced by healthcare workers during covid-19 pandemic Factors associated with mental health outcomes among health care workers exposed to coronavirus disease 2019 The emotional impact of coronavirus 2019-Ncov (new coronavirus disease) A systematic, thematic review of social and occupational factors associated with psychological outcomes in healthcare employees during an infectious disease outbreak Healthcare providers on the frontlines: a qualitative investigation of the social and emotional impact of delivering health services during Sierra Leone's Ebola epidemic Healthcare workers emotions, perceived stressors and coping strategies during a MERS-CoV outbreak Healthcare workers' attitudes to working during pandemic influenza: a qualitative study The Effect of COVID-19 Pandemic on the Mental Health of Canadian Critical Care Nurses Providing Patient Care during the Early Phase Pandemic: A Mixed Method Study. Intensive and Critical Care Nursing Mental health problems faced by healthcare workers due to the covid-19 pandemic -A review Mitigating the psychological effects of COVID-19 on health care workers Protecting our healthcare workers during the COVID-19 pandemic Psychometric properties of the Impact of Event Scale-Revised Manual for the Depression Professional Quality of Life: Compassion Satisfaction and Fatigue Version 5 (ProQOL) Cytokine storm and sepsis disease pathogenesis Enhancing Recovery From Sepsis: A Review The ketone metabolite betahydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics Empagliflozin suppresses inflammation and protects against acute septic renal injury Grant Acknowledgement: This work was supported by grants from the CIHR, Heart and Stroke Foundation, and Alberta Innovates Outcomes and Economics of Prolonged Mechanical Ventilation in Alberta: A 10 Canadian Institute for Health Information. Care in Canadian ICUs Long term survival of critically ill patients treated with prolonged mechanical ventilation: a systematic review and meta-analysis Long term Survival of Critically Ill Patients Treated with Prolonged Mechanical Ventilation: A Systematic Review and Meta-Analysis Prevalence and Intensive Care Bed Use in Subjects on Prolonged Mechanical Ventilation in Swedish Intensive Care Unit Epidemiology of Chronic Critical Illness in Japan: A Nationwide Inpatient Database Study Variation in mortality rates after admission to long-term acute care hospitals for ventilator weaning Prolonged Weaning from Mechanical Ventilation: Results from Specialized Weaning Centers-A Registry-based study from the WeanNet Initiative Using canadian administrative databases to derive economic data for health technology assessments. Ottawa:Canadian Agency for Drugs and Technologies in Health This study was funded by the Covenant Foundation Research Infrastructure Grant #360.CFND.1819.081 and the Alberta SPOR SUPPORT Unit Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patients The significance of Candida in the human respiratory tract: our evolving understanding. Pathog Dis The clinical significance of Candida colonization of respiratory tract secretions in critically ill patients Antifungal therapy in patients with pulmonary Candida spp. colonization may have no beneficial effects Mechanical ventilation in patients with acute brain injury: recommendations of the European Society of Intensive Care Medicine consensus Ratio of means for analyzing continuous outcomes in meta-analysis performed as well as mean difference methods Assessing bias in studies of prognostic factors Prognosis research strategy (PROGRESS) 1: A framework for researching clinical outcomes The PRISMA 2020 statement: an updated guideline for reporting systematic reviews Improving long-term outcomes after discharge from intensive care unit: report from a stakeholders' conference Guidelines for Family-Centered Care in the Neonatal, Pediatric, and Adult ICU Natural language processing to measure the frequency and mode of communication between healthcare professionals and family members of critically ill patients Performance of administrative case definitions for depression and anxiety in inflammatory bowel disease Systematic review and assessment of validated case definitions for depression in administrative data Association between delirium in the intensive care unit and subsequent neuropsychiatric disorders Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database Emergency department and inpatient coding for self-harm and suicide attempts: Validation using clinician assessment data The central role of the propensity score in observational studies for causal effects Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies Quality Improvement Interventions to Prevent Unplanned Extubations in Incidence, outcomes and outcome prediction of unplanned extubation in critically ill children: An 11year experience Unplanned Endotracheal Extubations in the Intensive Care Unit: Systematic Review, Critical Appraisal, and Evidence-Based Recommendations Revisiting unplanned extubation in the pediatric intensive care unit: What's new? The PRISMA 2020 statement: an updated guideline for reporting systematic reviews The behaviour change wheel: A new method for characterising and designing behaviour change interventions Development of the Quality Improvement Minimum Quality Criteria Set (QI-MQCS): a tool for critical appraisal of quality improvement intervention publications Intensive care readmission: A contemporary review of the literature. Intensive Crit Care Nurs Canadian Institute for Health Information. Care in Canadian ICUs A Comprehensive Review of the Outcome for Patients Readmitted to the ICU Following Trauma and Strategies to Decrease Readmission Rates The association between ICU readmission rate and patient outcomes Readmission of ICU patients: A quality indicator? Readmission to the intensive care unit: Incidence, risk factors, resource use, and outcomes: A retrospective cohort study Association of severity of illness and intensive care unit readmission: A systematic review. Hear Lung A nurse-led critical care outreach program to reduce readmission to the intensive care unit: A quasi-experimental study with a historical control group R: A Language and environment for statistical computing. R Foundation for Statistical Computing Prevent central line infections: Getting starter kit. Safer Healthcare Now Leaving more than your fingerprint on the intravenous line: a prospective study on propofol anesthesia and implication of stopcock contamination Microbial growth in propofol formulations with disodiumedetate and the influence of venous access system dead space Propofol: A review of its use in intensive care sedation of adults Representation of Black People in Critical Care Randomized Control Trials -A Systematic Review Tchouambou Youmbi Abubaker 7 ; Rochwerg, Bram 8 Canada 3 Critical Care Medicine, The Ottawa Hospital & Montfort Hospital, Ottawa, Canada 4 Pulmonary, Allergy, and Critical Care Medicine Randomised controlled trials-the gold standard for effectiveness research A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results Racial Variation in the Incidence, Care, and Outcomes of Severe Sepsis Understanding the Complexity of Heart Failure Risk and Treatment in Black Patients The epidemiology of intensive care unit-acquired hyponatraemia and hypernatraemia in medical-surgical intensive care units Renal Function is a Major Determinant of ICU-acquired Hypernatremia: A Balance Study on Sodium Handling Association between hypernatraemia acquired in the ICU and mortality: a cohort study The Effects of Pre-Existing Hyponatremia and Subsequent-Developing Acute Kidney Injury on In-Hospital Mortality: A Retrospective Cohort Study Higher Fluid Balance Increases the Risk of Death From Sepsis: Results From a Large International Audit Beca Estímulo Florencio Fiorini para Investigación en Medicina Prevalence of SARS-CoV-2 infection in previously undiagnosed health care workers in New Jersey, at the onset of the U.S. COVID-19 pandemic Risk of COVID-19 among frontline healthcare workers and the general community: a prospective cohort study. medRxiv Identifying airborne transmission as the dominant route for the spread of COVID-19 COVID-19 in Canada: Experience and Response Aerosol boxes and barrier enclosures for airway management in COVID-19 patients: a scoping review and narrative synthesis Aerosol Retention Characteristics of Barrier Devices Protective Barrier Enclosures Without Negative Pressure Used During the Covid-19 Pandemic May Increase Risk to Patients and Health Care Providers-Letter to Health Care Providers Measurement of airborne particle exposure during simulated tracheal intubation using various proposed aerosol containment devices during the COVID-19 pandemic Barrier enclosure use during aerosol-generating medical procedures: A scoping review Prognostic utility and characterization of cell-free DNA in patients with severe sepsis Protein C as an Early Marker of Severe Septic Complications in Diffuse Secondary Peritonitis Mortality Risk Profiles for Sepsis: A Novel Longitudinal and Multivariable Approach Time Course of Hemostatic Abnormalities in Sepsis and its Relation to Outcome Thrombomodulin is a Strong Predictor of Multiorgan Dysfunction Syndrome in Patients With Sepsis Endothelial Dysfunction Is Associated with Mortality and Severity of Coagulopathy in Patients with Sepsis and Disseminated Intravascular Coagulation Identification of hemostatic markers that define the pre-DIC state: A multi-center observational study Clinical investigation of the utility of a pair of coagulationfibrinolysis markers for definite diagnosis of sepsis-induced disseminated intravascular coagulation: A single-center, diagnostic, prospective, observational study Prevention of venous thromboembolism Risk factors for venous thromboembolism Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study Prophylactic and therapeutic inferior vena cava filters to prevent pulmonary emboli in trauma patients The effectiveness of prophylactic inferior vena cava filters in trauma patients: a systematic review and meta-analysis The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients Thromboembolism after trauma: an analysis of 1602 episodes from the American College of Surgeons National Trauma Data Bank Low-molecular-weight heparin in the treatment of patients with venous thromboembolism Systematic review of the use of retrievable inferior vena cava filters Inferior vena caval filters: review of a 26-year single-center clinical experience Early experience with retrievable inferior vena cava filters in high-risk trauma patients The use of prophylactic inferior vena cava filters in trauma patients: a systematic review Update on inferior vena cava filters Experience with the Amplatz retrievable vena cava filter Canadian Institute for Health Information 48 (18- Background: Intensive care unit (ICU) survivors are at risk for physical, cognitive, and psychiatric problems following ICU discharge. 1 Guidelines recommend in-person visitation between ICU patients and family members; family presence in the ICU is essential to ensure the well-being of critically ill patients during their ICU stay and postdischarge. 2 The effect of family visitation in the ICU on patients' post-hospital discharge psychiatric outcomes is unknown. Objective: The objective of this study was to estimate the association between family visitation in the ICU and incidence of psychiatric outcomes in ICU patients 1-year posthospital discharge. Methods: Population-based retrospective cohort of adult patients admitted to one of 14 medical-surgical ICUs from January 1, 2014 to May 30, 2017 surviving to hospital discharge with an ICU length of stay ³3 days. To be eligible patients needed to have at least 5-years of administrative health data prior to ICU admission (to exclude preexisting psychiatric disorder) and at least 1-year of follow-up data post-hospital discharge. An internally validated algorithm that interpreted natural language in the health record determined patients with or without in-person family (i.e., relatives, friends) visitation during their ICU stay. 3 The primary outcome was risk of an incidence of psychiatric disorder (composite outcome) including anxiety, 4 depressive, 5 traumaand stressor-related, 6 psychotic, 7 and substance use disorders 7 that were identified using coding algorithms for administrative health databases. A validated coding algorithm identified people who experienced a suicide attempt or event of selfharm. 8 Propensity scores 9 were used in inverse probability weighted logistic regression models and average treatment effects were converted to risk ratios (RR) with 95% confidence intervals (95%CIs). 10 Secondary outcomes were incidences of diagnoses by type of psychiatric disorder. Results: We included 14,344 patients with and without in-person family visitation who survived to hospital discharge. Over one-third of patients were diagnosed with incidence of any psychiatric disorder within 1-year post-discharge (34.9, 95%CI: 34.1%-35.6%). Patients were most often diagnosed with incidence of anxiety disorders (17.5%, 95%CI: 16.9%-18.1%) and incidence of depressive disorders (17.2%, 95%CI: 16.6%-17.9%); 216 patients experienced a suicide attempt or event of self-harm (1.5%, 95%CI: 1.3%-1.7%). After inverse probability weighting of 13,731 patients, in-person family visitation was associated with lower risk of being diagnosed with any incident psychiatric disorder within 1-year post-discharge (RR 0.87, 95%CI: 0.79-0.97), and mostly lower risk of a trauma-and stressor-related disorder (RR 0.66, 95%CI: 0.38-0.87). Conclusion: Critically ill patients with in-person family visitation had decreased risk for psychiatric disorders up to 1-year after hospital discharge. Critically ill patients with family visitation also had decreased risk for trauma-and stressor-related disorders. Given the high incidence all patients, family members, and primary care physicians should be made aware of the risk and those without visitation should perhaps be identified as being at higher risk. [1] [2] [3] Objective: The objective of this review is to comprehensively synthesize literature published on quality improvement (QI) practices implemented to reduce the rate of unplanned extubations in critically ill children. Methods: This systematic review was conducted and reported according to the Preferred Reporting Items for Systematic Review and Meta-analyses (PRISMA) 2020 reporting guidelines 4 and was registered on PROSPERO (CRD42021252233) prior to data extraction. A search was conducted in MEDLINE, Embase, and CINHAL from inception through April 29, 2021, and two reviewers independently screened citations in duplicate using pre-determined eligibility criteria. Data from included studies were abstracted using a tool created by the authors, and QI interventions were categorized using the Behavior Change Wheel. 5 Study quality was assessed using the Quality Improvement Minimum Quality Criteria Set (QI-MQCS). 6 Results were presented as descriptive statistics and narrative syntheses. Results: Twelve studies were included in the final review. Ten described primary QI projects; two were sustainability studies that followed up on previously described QI interventions. Half of the included studies were rated as high-quality. The median number of QI interventions described by each study was 4.5 , with a focus on guidelines, environmental restructuring, education, training, and communication. Nine studies reported decreased unplanned extubation rates after the QI intervention; of these, six were significant (p<0.05). Both sustainability studies observed increased rates that were not statistically significant. Conclusion: This review provides a comprehensive synthesis of QI interventions to reduce unplanned extubation rates. With only half the studies achieving a high-quality rating, there is room for improvement when reporting research in this area. Findings from this review can be used to support clinical recommendations to prevent unplanned extubations, positively support patient safety in pediatric critical care. Laura Miller Introduction: Readmission to the Intensive Care Unit (ICU) is defined as a return to ICU during the same hospitalization. (1) According to the Canadian Institute for HealthInformation, Canada's overall 48-hour ICU readmission rate was 1% in 2016 (2) . Canada's readmission rates are comparable internationally, with rates ranging from 1.3-13.7% in countries such as Brazil, France, Taiwan, Netherlands and Australia (1) . ICU readmission is associated with a variety of adverse outcomes including increased mortality rates, length of stay, and healthcare costs. (3) (4) (5) (6) (7) Determining predictors of ICU readmission may help identify patients most at risk of readmission, support protocols intended to reduce ICU readmission, thereby contributing potentially to a reduction of associated adverse outcomes. (8) In Nova Scotia (NS), there has been no research to date on predictors of ICU readmission or characteristics of patients readmitted to ICU. Closer study of ICU readmission in NS will help to inform work to reduce ICU readmissions and potentially improve outcomes. Objectives: 1) To describe the rate of ICU readmissions in Nova Scotia. 2) To determine the impact of ICU readmission on patient outcomes. 3) To determine which variables are predictive of ICU readmission, and to generate a model to help predict which patients have the highest probability of readmission. Methods: We conducted a retrospective review of data collected in the Nova Scotia (NS) provincial ICU database. We included all patients admitted to one of twelve adult ICUs in NS between April 1, 2018 and March 31, 2021. All data were analyzed using the statistical programming language R (R Core Team 2020). (9) Descriptive statistics on ICU readmission were generated. A linear mixed effects model was fit to examine differences in mortality based on ICU readmission. A generalized linear mixed effects model was used to predict ICU readmission from the following predictor variables identified a priori: APACHE IV predicted mortality, age, diagnosis, need for ventilation in the first 24 hours, ICU admission location, location prior to ICU admission, occurrence of delirium during ICU stay, and mobility level. Results: A total of 12,395 patients were admitted to ICU in NS between April 2018 and March 2021, with 217 (1.75%) of these patients readmitted to ICU during their hospitalization. Readmission rates in the 12 ICUs in NS ranged from 0.40-3.94%. ICU readmission was associated with a 63.8% increase in odds of mortality (p<0.004). Higher APACHE IV predicted mortality and occurrence of delirium during ICU stay were significant predictors of ICU readmission (p < 0.05). The current study is significant as it provides the first examination of ICU readmission in Nova Scotia. ICU readmission rates in NS are comparable to the Canadian average. ICU readmission is associated with a large increase in risk of mortality. This data strengthens the need for further study on reducing ICU readmissions and the potential effect this may have on outcomes. Our work has shown that higher APACHE IV predicted mortality as well as occurrence of delirium during ICU stay are predictors of readmission. These findings can help target future interventions to those most at risk of readmission. Future work on reducing ICU readmission should closely examine how any reduction in readmissions affects outcomes.Introduction: Catheter-related blood stream infection (CR-BSI) has an average mortality rate between 4% and 20%. Central line infections (CLI) prolong hospital stay by approximately seven days, increasing cost by $3,700 to $29,000 USD. Humber River Hospital experienced an increased incidence of CLI in Intensive Care Unit (ICU) between November 2020 and February 2021. A total of five CLI cases were confirmed, with three from internal jugular central lines, and two from Peripherally Inserted Central Catheters (PICC). Practice gaps identified include noncompliance with best practices. Educational huddles conducted on central line care and maintenance Practice tip sheet developed Implemented Safer Health Now's Central Line Care and Maintenance Bundle Audits were conducted to monitor compliance with central line dressing and IV tubing change date PICC insertion observed by Infection Prevention and Control coordinator and feedback provided Results: Through discussion, case studies, collaborative learning and the reinforcement of preventive strategies on central line care and maintenance, the ICU was able to eliminate CLI in admitted patients. Since March 2021 to September 2021, zero incidence of CLI was reported. Continuous education and support were provided to maintain best practice. Methods: In this qualitative study, family members of 28 hospitalized patients who died between March and July 2020 were interviewed. Patients and families were enrolled from three acute care units in a Canadian tertiary care hospital. Qualitative semistructured interviews inquired about family experiences before and beyond the death of their loved one, and garnered suggestions to improve end-of-life care. Data collection and analysis used a qualitative descriptive approach to conventional content analysis. Results: Pandemic restrictions had consequences for families of dying hospitalized patients. Most family members described an attitude of acquiescence, some framing their experience as a sacrifice made for the public good. Families appreciated how clinicians engendered trust in the name of social solidarity as they attempted to mitigate the negative impact of family separation. However, fears about the patient's experience of isolation and changes to post-mortem rituals also created despair and contributed to long-lasting grief. Conclusion: Profound loss and enduring grief were described by family members whose final connections to their loved one were constrained by pandemic-related restrictions. Families observed solidarity among clinical staff, and sense of unity with staff, which alleviated some distress. Improvements to end-of-life care under these circumstances may include frequent communications, exceptions for family presence when safe, and targeted efforts to connect patients whose isolation is intensified by functional impairment or limited technologic access. Introduction: An increase in plasma sodium (Na) during the recovery of acute kidney injury (AKI) has been described among critically ill patients. Both hypernatremia (HPNa, defined as Na 145 mEq/L) and a positive fluid balance, which may result from free water used to treat HPNa, are associated with increased morbidity and mortality. Objectives: The objective of this study was to evaluate the association between daily fluid balance and daily PNa during the recovery phase of AKI among critically ill patients. As secondary objectives, we described the incidence and risk factors for Na increases and HPNa. Methods: Eligible patients (>18 years old with AKI at or following intensive care unit [ICU] admission) were consecutively enrolled from four mixed medical-surgical ICUs from Buenos Aires, Argentina (March 2019-February 2020). AKI was defined according to KDIGO guidelines. Exclusion criteria comprised conditions associated with specific objectives for fluid or sodium management: chronic kidney disease (CKD), pregnancy, burns, open abdomen, central nervous system pathology, and acute or chronic treatment with antidiuretic hormone or analogues. Day zero was defined as the peak day of creatinine; patients were followed up for 4 days or until ICU discharge or initiation of renal replacement therapy, whichever came first. The main outcome was daily Na, and the main exposure was daily fluid balance (fluid intake-urine output). Demographic characteristics, baseline severity of illness, and daily creatinine, urea, and potassium were recorded. To estimate the effect of daily fluid balance on daily Na, we fitted a general estimating equations (GEE) model with an autoregressive correlation structure and robust standard errors; this model generated beta-coefficients with 95% confidence intervals (CIs). Multivariable logistic regression was used to identify risk factors associated with HPNa, expressed as odds ratios (ORs) with 95%CI. Results: 93 patients were included, with median age 66 years (IQR 54.5-78); 63 (67.8%) were male. 73 patients (78.5%) completed the 4-day follow-up period. Among 20 patients who did not complete follow-up, 18 (19.4%) were discharged from ICU, 1 (1.1%) died and 1 (1.1%) required renal replacement therapy. The mean APACHEII score at ICU admission was 17.7 (SD 7.3) and ICU mortality was 11/93 (12.5%; Table 1 ). 81 patients (87.1%) had an elevation of Na during AKI recovery, and 50 patients (53.7%) had a Na 145 mEq/L. Over the follow-up period, the mean daily fluid balance was +0.70 L (SD 1.65), the median daily fluid intake was 2.80 L (IQR 2.15-3.78), the median daily diuresis was 2.00 L (IQR 1.40-2.90). We found no significant effect of daily fluid balance, fluid intake, or urine output on daily Na ( Table 2 ). The development of HPNa was independently associated with Na at day zero (OR 1.36, 95%CI 1.17 -1.57; p <0.001) and urea at day zero (OR 1.02, 95%CI 1.01 -1.03; p=0.045), but was were also limited by a lack of the quality reporting in the included studies and a lack of sensitivity & specificity data to explain PC utility in clinical practice. Overall, our results provide a rationale for future robust biomarker studies evaluating PC's use as a biomarker for early sepsis detection and routine use in sepsis prognosis. Background/Introduction: Randomized control trials (RCTs) provide essential evidence to inform treatments. However, there are many necessary and timeconsuming steps from idea generation to enrollment of patients. Lengthy times to initiate RCTs are particularly problematic for treatment RCTs for emerging infections causing large outbreaks and pandemics, such as COVID-19. Purpose: We aimed to determine the duration the time to complete various steps of a CIHR-funded Health Canada regulated multi-centre drug treatment RCT in Canada (Canadian Treatments for COVID-19, CATCO), to identify areas for improved efficiency in the trial initiation process. Materials and Methods: All participating CATCO hospital sites were surveyed using a structured data abstraction form. We measured the durations from protocol receipt to site activation and initiation of patient enrollment, and also durations of administrative processes including research ethics board (REB) approval, contract execution, and the lead-time between contract execution to initiation of site activation and patient enrollment. Results: Among 52 (academic hospitals (N=27), community hospitals (N=21) and central submission sites (N=4)) Canadian institutions surveyed, all sites responded, across 7 Canadian provinces (AB, BC, MN, SK, ON, QC, NS). 15 sites (academic hospitals (N=8), community hospitals (N=7)) provided the requested data completely. The median (interquartile range) time from receipt of the protocol receipt to initiation of patient enrollment was 169 (49, 227) days. The durations for REB approval and full contract execution were 5 (1, 12) and 25 (16, 63) days respectively. The lead time from REB approval to enrollment of first patient was 114 (27, 170) days and 63 (10, 135) days from full contract execution to enrollment of first patient. In a stratified analysis, academic hospitals required less time for site activation and initiation of patient enrollment after REB approval and contract execution compared to community hospitals. Conclusions: Even with broad-based motivation to expedite research, there was considerable variation in the time required to initiate a large multi-centre pandemicfocused clinical trial RCT in Canada. While REB approvals generally happened quickly, contract executions were typically prolonged, and start-up activities post contract execution variable. Having standardized contract templates and greater pre-existing site-level research infrastructure might shorten the time to initiate pandemic focused clinical trials in Canada, especially in community hospitals.